Lingual vs. labial fixed orthodontic appliances: systematic review and meta-analysis of treatment effects by Papageorgiou, Spyridon N et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Lingual vs. labial fixed orthodontic appliances: systematic review and
meta-analysis of treatment effects
Papageorgiou, Spyridon N; Gölz, Lina; Jäger, Andreas; Eliades, Theodore; Bourauel, Christoph
Abstract: The aim of this systematic review was to compare the therapeutic and adverse effects of lingual
and labial orthodontic fixed appliances from clinical trials on human patients in an evidence-based manner.
Randomized and prospective non-randomized clinical trials comparing lingual and labial appliances were
included. Risk of bias within and across studies was assessed using the Cochrane tool and the Grading of
Recommendations Assessment, Development and Evaluation (GRADE) approach. Random-effects meta-
analyses were conducted, followed by subgroup and sensitivity analyses. Six electronic databases were
searched from inception to July 2015, without limitations. A total of 13 papers pertaining to 11 clinical
trials were included with a total of 407 (34% male/66% female) patients. Compared with labial appliances,
lingual appliances were associated with increased overall oral discomfort, increased speech impediment
(measured using auditory analysis), worse speech performance assessed by laypersons, increased eating
difficulty, and decreased intermolar width. On the other hand, lingual appliances were associated with
increased intercanine width and significantly decreased anchorage loss of the maxillary first molar during
space closure. Based on existing trials, there is insufficient evidence to make robust recommendations
for lingual fixed orthodontic appliances regarding their therapeutic or adverse effects, as the quality of
evidence was low.
DOI: https://doi.org/10.1111/eos.12250
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-133038
Accepted Version
Originally published at:
Papageorgiou, Spyridon N; Gölz, Lina; Jäger, Andreas; Eliades, Theodore; Bourauel, Christoph (2016).
Lingual vs. labial fixed orthodontic appliances: systematic review and meta-analysis of treatment effects.
European Journal of Oral Sciences, 124(2):105-118.
DOI: https://doi.org/10.1111/eos.12250
1 
 
Title Page 
Lingual versus labial fixed orthodontic appliances: systematic review and 
meta-analysis of treatment effects 
 
Spyridon N. Papageorgiou1,2, Lina Gölz1, Andreas Jäger1, Theodore Eliades3, Christoph Bourauel2 
 
1Department of Orthodontics, School of Dentistry, University of Bonn, Welschnonnenstr. 17, 53111, 
Bonn, Germany; 2Department of Oral Technology, School of Dentistry, University of Bonn, 
Welschnonnenstr. 17, 53111, Bonn, Germany; 3Clinic of Orthodontics and Paediatric Dentistry, 
Center of Dental Medicine, Faculty of Medicine, University of Zurich, Plattenstrasse 11, Zurich 8032, 
Switzerland 
 
Running title: Lingual versus labial fixed appliances 
 
Corresponding author: Spyridon N. Papageorgiou, Department of Orthodontics, School of Dentistry, 
University of Bonn, Welschnonnenstr. 17, 53111, Bonn, Germany. Tel.: +49-(0)228-287-22449; Fax: 
+49-(0) 228-287-22588; E-mail: snpapage@gmail.com. 
 
Words in abstract: 200 
Words in text: 4064 
 
Keywords: orthodontics, fixed appliances, lingual appliances, labial appliances, systematic review, 
meta-analysis 
2 
 
Papageorgiou SN, Gölz L, Jäger A, Eliades T, Bourauel C. Lingual versus labial fixed orthodontic 
appliances: systematic review and meta-analysis of treatment effects. Eur J Oral Sci 2015. 
 
Abstract 
Aim of this systematic review was to compare the therapeutic and adverse effects of lingual and labial 
orthodontic fixed appliances from clinical trials on human patients in an evidence-based manner. 
Randomized and prospective non-randomized clinical trials comparing lingual and labial appliances 
were included. Risk of bias within and across studies was assessed with the Cochrane tool and the 
GRADE approach. Random-effects meta-analyses were conducted, followed by subgroup and 
sensitivity analyses. Six electronic databases were searched from inception to July 2015 without 
limitations. A total of 13 papers pertaining to 11 clinical trials were included with a total of 407 (119 
male / 228 female) patients. Lingual appliances were associated with increased overall oral discomfort 
compared to labial appliances, increased speech impediment (measured with auditory analysis), worse 
speech performance assessed by laypersons, increased eating difficulty, and decreased intermolar 
width. On the other side, lingual appliances were associated with increased intercanine width and 
significantly decreased anchorage loss of the maxillary first molar during space closure. Based on 
existing trials, there is insufficient evidence to make robust recommendations for lingual fixed 
orthodontic appliances regarding their therapeutic or adverse effects, as the quality of evidence was 
low. 
Registration: PROSPERO (CRD42015024596) 
Conflict of interest: None 
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Manuscript 
 
Introduction 
Rationale 
Fixed appliance treatment has become an integral part in modern orthodontics and has been a major focus point 
of orthodontic research. Traditionally, orthodontic appliances have been fixed on the outer (labial) surface of the 
teeth (hereon labial appliances). In recent years, the increased number of adult patients seeking orthodontic 
treatment (1) and their higher esthetic demands (2) have led to the development of various esthetic treatment 
approaches including esthetic brackets, clear aligners, and appliances fixed on the inner (lingual or palatal) 
surface of the teeth (hereon lingual appliances). 
Since introduction of lingual appliances by Fujita (3), progress has been seen in their design, 
manufacturing, and mechanotherapy. Advantages of lingual appliances proposed by clinicians or manufacturers 
include lower noticeability, fewer white spot lesions and caries, lighter forces being needed due to smaller 
interbracket distance, smaller anchorage loss, and increased comfort (2, 4, 5). Possible disadvantages include 
practical difficulties in the insertion and handling of these appliances, longer chairtimes for patients and 
orthodontists, higher laboratory costs, and poorer outcomes compared to labial appliances. The development of 
new archwire materials, advanced laboratory techniques, and the widespread use of sophisticated computer 
programs have reintroduced lingual appliances as a promising and a competing technique by trying to alleviate 
or overcome some of the abovementioned disadvantages. 
Existing systematic assessment of orthodontic fixed appliances are limited and problematic (6, 7). 
Current evidence on lingual appliances has been previously quantitatively assessed (8, 9). However, conclusions 
may have been distorted by inclusion of retrospective studies (10), limited identification of eligible trials, or 
issues during their qualitative/quantitative data synthesis (11, 12). In particular, assessment of the quality of 
evidence with the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach 
(13) and their translation in future clinical settings (14) could aid in drawing robust conclusions. 
 
Objectives 
Aim of this study was to compare the treatment effects of lingual appliances compared to labial appliances from 
randomized and prospective non-randomized clinical trials conducted on human patients. 
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Materials and Methods 
Protocol and registration 
The protocol for this review was made a priori based on the PRISMA-P statement (15), registered in 
PROSPERO (CRD42015024596), and all post hoc changes were appropriately noted. This systematic review 
was conducted and reported according to Cochrane Handbook (16) and PRISMA statement (17), respectively.  
 
Eligibility criteria 
According to the PICOS schema, included were parallel or split-mouth randomized and non-randomized 
prospective controlled trials on human patients comparing any lingual appliance to any labial appliance and 
assessing its therapeutic effects (both effectiveness and efficiency) or adverse effects. Excluded were non-
clinical studies, retrospective studies, and studies with partial appliances (appliance not placed on all teeth 
excluding second and third molars). 
 
Information sources and literature search 
A total of six electronic databases were searched systematically by one author (SNP) without any limitations 
from inception up to July 20th, 2015 (Appendix 1). Four additional sources (Scopus, Google Scholar, 
ClinicalTrials.gov, and ISRCTN registry) were manually searched for additional trials or protocols by the same 
author. Authors of included trials were contacted for additional missed or ongoing trials. No limitations 
concerning language, publication year or status were applied. The reference lists of the included trials and 
relevant reviews were manually searched as well. 
 
 Study selection 
Titles identified from the search were screened by one author (SNP) with a subsequent duplicate independent 
checking of their abstracts/full-texts against the eligibility criteria by two authors (SNP, LG), while conflicts 
were resolved by a third author (AJ). 
 
 Data collection 
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Characteristics of included trials and numerical data were extracted in duplicate by two authors (SNP, LG) using 
pre-determined and piloted extraction forms. Piloting of the forms was performed during the protocol stage until 
over 90% agreement was reached. Missing or unclear information was requested by the trials’ authors. 
 
Risk of bias in individual trials 
The risk of bias of the included trials was assessed using Cochrane’s risk of bias tool (16) after initial 
calibration. A main risk of bias assessment was included in the systematic review pertaining to each trial’s 
primary outcome. 
 
Data synthesis 
As the outcome of fixed appliance therapy is bound to be affected by the bracket (7), the wire (6), and their 
interaction (18), a random-effects model according to DerSimonian and Laird was deemed appropriate to 
incorporate this variability (11). 
For parallel trials the Mean Difference (MD) and the Relative Risk (RR) with their corresponding 95% 
Confidence Interval (CI) were chosen as effect measures for continuous and binary outcomes, respectively. The 
RR was chosen over the Odds Ratio (OR), due to its comparative advantages (18). For split-mouth trials the raw 
data were requested from the trial’s authors and clustering-adjusted estimates were calculated with univariable 
and multivariable regression modeling. In case similar outcomes were assessed both as binary and continuous, 
the Standardized Mean Difference (SMD) was chosen to pool them after conversion according to Chinn (20). 
The number needed to treat was planned to be used to clinically translate the results of statistically significant 
meta-analyses of binary outcomes. 
Between-trial heterogeneity was quantified with the I² statistic, defined as the proportion of total 
variability in the results explained by heterogeneity, and not chance (21, 22). The 95% uncertainty intervals 
(95% UI) (similar to CIs) around the I2 were calculated (23) using the non-central χ2 approximation of Q (24). 
95% predictive intervals were calculated for meta-analyses of three trials or more, which incorporate existing 
heterogeneity and provide a range of possible effects for a future clinical setting (14). All analyses were run in 
Stata SE 10.0 (StataCorp, College Station, TX) by one author (SNP). A two-tailed P-value of 0.05 was 
considered significant for hypothesis-testing, except for a 0.10 used for the test of heterogeneity and reporting 
biases, due to low power (25).  
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Risk of bias across studies 
The overall quality of evidence (confidence in effect estimates) for each of the main outcomes was rated using 
the GRADE approach (13). For this assessment, the risk of bias of each included trial was re-assessed separately 
at outcome level. 
The minimal clinical important, large, and very large effects were conventionally defined (26) as half, 
one, and two standard deviations, respectively. The standard deviation for an outcome was averaged from the 
existing trials. Conventional cut-offs of 0.2, 0.5, and 0.8 were adopted for the SMD. The produced forest plots 
were augmented with contours denoting the magnitude of the observed effects. Finally, the optimal information 
size (i.e. required meta-analysis sample size) was calculated for each outcome independently for α = 5% and β = 
20%. 
 
Additional analyses 
Possible sources of heterogeneity were planned to be sought through pre-specified mixed-effects subgroup 
analyses and random-effects meta-regression with the Knapp-Hartung adjustment (27), should at least five trials 
be pooled. Indications of reporting biases (including small-study effects) were planned to be assessed with 
Egger’s linear regression test (28) and contour-enhanced funnel plots, should ten or more trials be pooled. 
 
Sensitivity analyses 
As prospective non-randomized trials were also planned to be included in addition to randomized controlled 
trials (RCTs), a sensitivity analysis was planned to be conducted by including only RCTs and compared with the 
original analysis. Additionally, a post hoc exploratory analysis was performed to assess the overall difference 
between randomized and non-randomized trials on lingual appliances, adopting a quantitative approach (10). All 
meta-analyses were converted to SMDs on the same effect direction and differences according to the trial design 
were expressed as differences in SMDs (ΔSMDs) through random-effects meta-regression and pooled across 
meta-analysis via random-effects meta-analysis. Additional sensitivity analyses were planned, but were not 
conducted due to the limited number of included trials. 
 
Results 
Study selection 
7 
 
A total of 123 and 7 papers were identified through the electronic (Appendix 1) and manual searches, 
respectively (Fig. S1). After removal of duplicates and initial screening, 31 papers were judged against the 
eligibility criteria, leaving a final number of 13 included papers (29, 41), (Fig. S1; Appendix 2; Table 1). In two 
instances duplicate publications pertaining to the same trial were grouped together, leaving a total of 11 finally 
included trials.  
 
Study characteristics 
The characteristics of the included trials can be seen in Table 1 and Appendix 3. Out of the 11 included trials, 
three (27%) were parallel RCTs, one (9%) was split-mouth RCT according to treated jaw, and the remaining 
seven (64%) were parallel prospective non-RCTs. They included a total of 407 patients (with at least 119 male 
and 228 female patients) with an average age of 21.3 years. The majority (73%) of the lingual appliance groups 
and all (100%) of the labial appliance groups pertained to pre-fabricated appliances, while three trials (23%) 
used individualized lingual appliances for each patient (Incognito® appliance, 3M-Unitek, Monrovia, Calif; 
formerly, TOP Service for Lingualtechnik, Bad Essen, Germany). Only six trials (55%) reported, even partially, 
information on the used archwires. Out of these six trials, four of them (66%) used pre-fabricated archwires for 
both lingual and labial groups, while two trials (33%) used individualized archwires for the lingual and pre-
fabricated archwires for the labial group. 
 
Risk of bias within studies 
The risk of bias assessment for the eleven included trials can be seen in Fig. 1 and Appendix 4. Serious 
methodological inadequacies were found in all trials for at least one bias domain. Most problematic domains 
were the inadequate/inexistent randomization (high risk in 64% of the trials) and blinding of outcome assessors 
(missing in 73% of the trials).  
 
Results of individual studies and data synthesis 
The results of all individual included studies are quantitatively represented in Appendix 5, while the results of 
all performed meta-analyses with 2 or more studies are given in Table 2. In all instances the MD and the RR 
was used for continuous and binary outcomes, respectively. In one instance crude and adjusted ORs and 
incidence rate ratios were used to express the raw trial data of van der Veen et al. (38) that were re-analyzed 
with univariable and multivariable binomial/negative binomial regression modeling. For the outcome of oral 
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discomfort, the binary questionnaire measurements of Khattab et al. (30) and Caniklioglu and Oztürk (29) were 
combined with the continuous Likert scale measurements of Shalish et al. (35) by expressing all three trials in 
SMDs. 
Shortly, lingual appliances were associated with the following beneficial effects (P < 0.05): less 
appliance noticeability, less discomfort at the cheeks, greater increase of the intercanine width with subsequent 
less needed interproximal enamel reduction, less anchorage loss of the posterior segment during space closure, 
and less white spot lesions compared to labial appliances. On the other side, lingual appliances were associated 
with the following detrimental effects (P < 0.05): greater oral hygiene problems (food impaction), worse oral 
hygiene (greater plaque index), greater tongue discomfort, greater oral pain, greater oral discomfort, greater 
overall irritation of the soft tissues, greater general activity problems, greater sleep disturbance, worse speech 
performance (measured as a greater impact on the upper frequency of the /s/ sound via auditory analysis, as well 
as assessment by specialists or laypersons), greater perception of articulation change, greater avoidance of 
certain types of conversations, and greater eating problems. However, the vast majority of comparisons were 
informed from a single included trial. 
 
Risk of bias across studies 
This paper is mainly focused on seven primary outcomes that were selected for assessment in the GRADE 
analysis (Table 3; Appendix 6): patient-reported oral discomfort, objective speech performance by measuring 
the upper frequency of the /s/ sound via auditory analysis, subjective speech performance assessed by 
laypersons, eating difficulty, intercanine width, intermolar width, and sagittal anchorage loss. 
 Lingual appliances were associated with increased overall oral discomfort compared to labial 
appliances, greatly increased speech impediment (measured with auditory analysis or assessed from laypersons), 
greatly increased eating difficulty, significantly increased intercanine width, slightly decreased intermolar width, 
and significantly decreased sagittal anchorage loss of the maxillary first molar during space closure (Fig. 2). 
However, the quality of all included analyses was judged very low, due to high risk of bias of included trials, 
inconsistency, and imprecision. 
 
Additional analyses 
Subgroup analyses and assessments of reporting biases were planned, but could not be performed due to the 
limited number of trials included in the meta-analyses. 
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The sensitivity analysis according to the improvement of the GRADE score by including only 
randomized trials is seen in Appendix 7. Apart from two outcomes that no randomized trials were eligible, the 
sensitivity analysis indicated that non-randomized trials considerably underestimated the difference between 
lingual and labial brackets. Indeed, the results in two out of five of the remaining outcomes were not statistically 
significant in the original analysis, but were statistically significant in the sensitivity analysis. Finally, the 
overall comparison of randomized and non-randomized trials indicates that the latter report significantly more 
beneficial effects of lingual appliances compared to the former (Appendix 8). This can be regarded as evidence 
of bias stemming from prospective non-randomized trials, the magnitude of which is considered as very large 
(ΔSMD = -1.28; 95%CI = -2.24,-0.32; P = 0.009). 
 
Discussion 
Summary of evidence 
This systematic review included 4 randomized and 7 non-randomized trials and a total of 407 patients. A 
considerable lack of evidence exists regarding the therapeutic effects of lingual appliances, especially pertaining 
to the long-term. Most trials are small non-randomized trials that investigate short-term adverse effects with 
serious limitations in their planning, conduct, and reporting. 
 Lingual appliances were associated with higher overall oral discomfort compared to labial appliances. 
However, caution is indicated in the interpretation of this finding as the original and the sensitivity analysis 
agreed on the direction, but not on the magnitude of this effect, resulting in a GRADE of very low to moderate 
(Appendix 7). Additionally, the localization of discomfort was different between lingual and labial appliances. 
Specifically, patients with lingual appliances were 58% less likely to report discomfort on the cheeks and 238% 
more likely to report discomfort on the tongue compared to patients with labial appliances (Appendix 5), which 
agrees with previous reports (42, 43). Finally, the overall pain intensity reported at the first two treatment weeks 
was significantly higher in patients with lingual appliances compared to patients with labial appliances (MD = 
11.9 mm in Visual Analogue Scale; Appendix 5). It should be taken in mind that oral discomfort and pain 
experience during orthodontic treatment is associated with patient age, personal values, and expectations (44, 
45), while the majority of oral discomfort occurs within the first month and diminishes afterwards (46). Some 
authors have suggested that low-profile brackets should restrict less the functional space of the tongue and 
induce less discomfort. This was not however the case, as the results of Shalish et al. (35) that used low-profile 
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Incognito® brackets did not differ from the results of Caniklioglu and Oztürk (29) that used bulkier Ormco 7th 
Generation® brackets (SMDs of 0.61 and 0.62, respectively; Fig. 2). 
Lingual appliances were associated with an increased speech impediment compared to labial 
appliances, which was seen both via auditory analysis of the /s/ sound and via subjective judgment of speech 
pathologists or laypersons on a Likert scale (Appendix 5). Again however, caution is indicated, as the GRADE 
for these meta-analyses was very low to moderate and effects might have been underestimated (Appendix 7). 
Additionally, patients with lingual appliances were more likely to report a perception of articulation change and 
avoidance of some types of conversations after 3 months compared to patients with labial appliances (Appendix 
5). This agrees with previous reports (42, 43), although speech disturbances might depend on the language used 
in each trial (29). However, the /s/ sound that was chosen for this analysis is especially sensitive and common in 
most languages (47), indicating robustness of this method. The pathomechanism of speech impairment during 
lingual appliance therapy stems from the contact area of the tongue being shifted further palatally due to the 
existence of lingual brackets (48). Speech disturbances induced by lingual brackets might be associated with the 
brackets’ design (30) and it is worth noting that speech disturbances may lead to greater social embarrassment 
than visible labial brackets (41). 
Patients with lingual appliances were considerably more likely to report eating difficulties compared to 
patients with labial appliances (435% to 800% more likely, according to the original and the sensitivity analysis, 
respectively). Again, eating difficulties are mainly reported in the majority of patients within the first month 
mainly (46). A possible explanation for prolonged eating difficulties might be the posterior disocclusion caused 
by the bite planes incorporated on the maxillary anterior lingual (palatal) brackets that were used (29). 
Treatment with lingual appliances was associated with a distinct increase in the intercanine width and 
decrease in the intermolar width of treated patients (Appendix 5). However, these results must be seen with 
caution. First of all, the GRADE quality was very low to low, mainly due to small samples and inconsistency. 
Additionally, dental arch dimensions are not directly relevant to the type of fixed appliances, as the influence of 
specific treatment mechanics and of the archwire properties (7), might act as a confounder. Indeed, both 
included trials were problematic in this aspect. Khattab et al. (31) used pre-fabricated wires for the labial group, 
but individualized wires for the lingual group. On the other hand, Soldanova et al. (37) used wire sequences that 
differed in the material, size, and cross-section between the lingual and labial groups, which can affect the 
results (7) and introduce bias. Regarding the increased intercanine width, the prominence premolar offset 
incorporated in the lingual wire together with the small interbracket distance in the anterior region might be the 
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explanation (31). Regarding the decrease in intermolar distance, a possible explanation might be lingual 
appliances causing irritation of the tongue, moving it to a more posterior and inferior position, and thereby 
affecting the force equilibrium at the posterior teeth (31). For this reason, measures to increase the transverse 
molar anchorage with lingual appliances have been suggested by some authors (31).  
Lingual appliances were associated with significantly less sagittal anchorage loss (mesial movement) of 
the first maxillary molar after en masse retraction to close first premolar extraction spaces compared to labial 
patients (MD = -0.82 mm). Possible explanations for this pertain to smaller arch perimeter with lingual 
appliances leading to higher wire rigidity and better anchorage control during retraction (49), increased 
anchorage value of the posterior teeth due to nearness of the lingual brackets to the center of tooth resistance (5), 
and the force direction during space closure with lingual appliances, which leads to cortical bone anchorage due 
to buccal root torque and distal rotation of the molar crown (5). Although this effect was non-trivial, 
confirmatory RCTs are needed. 
Although not included in the GRADE analyses, due to space limitations, several other possibly 
significant differences were found between lingual and labial appliances. Lingual appliances were associated 
with a minimal, but distinct, worsening of oral hygiene (higher plaque index) compared to labial appliances 
(Appendix 7). Plaque deposits on the lingual gingival margins of the teeth might be more difficult to remove, 
especially with wider brackets and reduced interbracket distance (48), and if maintained, can cause gingival 
inflammation. These findings can be supported by previous studies reporting oral hygiene impairment (29, 50) 
and elevated plaque accumulation and gingivitis in patients with lingual appliances (42, 43). 
The impact of fixed appliances on the formation of new white spot lesions during orthodontic treatment 
was directly re-calculated from the raw data of van der Veen et al. (38), by taking into account within-patient 
correlations stemming from the split-mouth design of the trial. After adjusting for all possible confounders 
through multivariable regression, patients’ jaws treated with lingual appliances were associated with 
significantly fewer new white spot lesions compared to jaws treated with labial appliances (incidence of new 
white spots per patient jaw decreased by 72%; Appendix 5). Caries is a multifactorial phenomenon and its 
occurrence during orthodontic treatment is affected by the lower resting pH, increased volume of plaque, and an 
appliance-induced rapid shift in bacterial flora (32, 51). An explanation usually suggested for the lower caries 
risk with lingual appliances is the mechanical cleaning of the tongue on the lingual/palatal surfaces of the teeth, 
although the opposite was found from the present review. Another more viable explanation is an increased 
saliva flow on the lingual/palatal tooth surfaces keeping the pH high (52). In the single trial assessing this (32), 
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lingual appliances were associated with decreased salivary flow rate and buffering capacity, although this was 
not statistically significant (Appendix 5). Additionally, lingual appliances were associated with increased counts 
of Streptococcus mutans and Lactobacilli, but this was also not statistically significant, due to low sample size 
(Appendix 5). Caries activity has been negatively associated with increased counts of Streptococcus mutans and 
Lactobacilli (53, 54). It is however known that orthodontic treatment is accompanied by a transient short-term 
elevation of Streptococcus mutans levels, which decrease after the active treatment phase, and return to 
physiological levels after the removal of the retention appliances (55). 
Finally, treatment with lingual appliances was associated with smaller amounts of interproximal enamel 
reduction needed to create missing arch space compared to labial appliances (MD = -0.67 mm; Appendix 5). 
However, this outcome is directly associated with initial crowding, treatment-induced changes on the dental 
arch width (and subsequently the arch’s circumference), and the treatment protocol. As these factors were not 
taken into account in the original analysis, residual bias for this outcome cannot be ruled out.  
  
Strengths and limitations 
The strengths of this systematic review include the extensive unrestrictive literature search, the robust review 
procedures, the communication with trialists for clarifications, and the attempt to acquire and re-analyze 
appropriately the raw data of the included trials, as was done in the split-mouth trial of van der Veen et al. (38). 
Finally, this review improves on previous similar studies, as it was registered a priori, compared directly lingual 
to labial appliances, did not include biased retrospective trials, provided quantitative data for all included 
studies, assesss the quality of evidence with the GRADE approach, and the sensitivity analysis identified 
detrimental factors for the quality of clinical recommendations. 
 However, there exist also some limitations to this study. First and foremost, this systematic review 
could potentially suffer from the GIGO (garbage-in-garbage-out) principle. This pertains to the fact that the 
quality of existing trials comparing lingual and labial appliances is problematic, while mainly non-randomized 
trials exist. This might potentially influence the magnitude and direction of observed effects (10, 56, 57), as was 
seen firsthand in the performed sensitivity analyses. Furthermore, additional outcome data from trialists could 
not be obtained, apart from one instance. Moreover, the assessment of lingual and labial appliances could not be 
assessed in conjunction with (a) patient gender, (b) patient motivation, (c) whether the appliances were fully 
individualized or not, and (d) whether a direct or indirect bonding protocol was followed, although originally 
13 
 
planned. Finally, the limited number of included trials precluded robust assessments of heterogeneity, subgroup 
analyses, small-study effects and reporting biases. 
There is insufficient evidence at present to make robust recommendations for lingual fixed orthodontic 
fixed appliances regarding their therapeutic or adverse effects. Only two out of the eleven identified trials were 
randomized, while none were in low risk of bias. 
 
 Recommendations for clinical practice 
Due to the fact that the confidence in effect estimates from the original analysis is so low (very low GRADE), 
making recommendations based on them might be too speculative. Based on the effect estimates from the 
sensitivity analysis (moderate GRADE), orthodontists might reasonably expect more oral discomfort, speech 
impairment, and eating difficulty in patients with lingual appliances compared to patient with labial appliances. 
 
Recommendations for further research 
Parallel randomized controlled trials are needed in order to robustly compare lingual and labial orthodontic fixed 
appliances and should be preferred over non-randomized design, as clear evidence of bias was seen from the 
latter. These should ideally follow the CONSORT statement (58), be performed from multiple independent 
research centers and focus on long term outcomes pertaining to the completion of orthodontic treatment, 
possibly including the retention period. Primary focus should be thrown into objective measurements of 
therapeutic effects (like patient satisfaction and quality of life, the quality of final occlusion measured with the 
American Board of Orthodontics Objective Grading System, treatment duration, and relapse) or adverse effects 
(including root resorption, white spot lesions, gingival recessions, oral pain, oral discomfort, functional 
impairment, and cost of treatment). 
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Figure legends 
Fig. 1. Summary of the risk of bias of the trials included in this systematic review. 
 
. 
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Fig. 2. Contour-enhanced forest plot of the treatment effects with lingual and labial appliances: (a), oral discomfort; (b), upper boundary frequency of the \s\ sound in the 
middle of the word; (c), subjective speech performance; (d), eating difficulty measured with a Likert scale; (e), intercanine width; (f), intermolar width; (g), sagittal 
anchorage loss of the first maxillary molar during space closure. Color contours indicate increasing effect magnitude from the middle to the ends of the forest plot: small 
effects (white), moderate effects (light grey), large effects (dark grey), and very large effects (darker grey). 
 
.  
 
22 
 
 
23 
 
Tables 
Table 1 
Characteristics of the included trials 
Trial Design 
Patients 
(M/F) 
Mean 
age 
(yrs) 
App Product† 
Slot 
size 
Prescri
ption 
Prefab/ 
Indiv 
Bonding Outcomes 
Conflict of 
interest 
Caniklioglu 
2005 (28) 
pCCT 
University 
 Turkey 
60 
(21/39) 
17.9 
Ling 
Ormco 7th Generation 
(Ormco, Glendora, CA, 
USA) 
NR  Prefab 
Indirect (Max & 
Mand) with 
TARG+TR 
System® 
Pat-rep problems: discomfort/ tongue-lip-
cheek soreness/ eating, speech, and oral care 
difficulties/ adaptation period/ general 
problems (3 mos) 
Not 
mentioned 
Lab NR NR Roth Prefab 
Direct (Max & 
Mand) 
Khattab 
2013,‡,¥ (29) 
RCT 
University 
Syria 
34 
(13/21) 
21.3 
Ling 
Stealth®(American 
Orthodontics, Sheboygan, 
Wisc) 
0.022” Roth Prefab 
Indirect (Max) 
with TARG+TR 
System® 
Speech performance evaluated with auditive 
analysis / Pat-rep oral impairment using a 
Likert-scale: oral discomfort, speech 
impairment, mastication difficulties (Bef-Tx, 1 
mo, 3 mos) 
Not 
mentioned 
Lab 
Mini Master Series 
(American Orthodontics, 
Sheboygan, Wisc) 
0.022” Roth Prefab Direct (Max) 
Khattab 
2014,*,‡,¥ 
(30) 
RCT 
University 
Syria 
52 
(20/32) 
21.2 
Ling 
Stealth®(American 
Orthodontics, Sheboygan, 
Wisc) 
0.022” Roth Prefab 
Indirect (Max) 
with TARG+TR 
System® 
Intercanine-/ interpremolar-/ intermolar width; 
arch length; amount of enamel reduction (Bef-
Tx, after leveling/aligning) 
None 
Lab 
Mini Master Series 
(American Orthodontics, 
Sheboygan, Wisc) 
0.022” Roth Prefab Direct (Max) 
Lombardo 
2013 (31) 
RCT 
University/pr
actice (?) 
Turkey/Italy 
(?) 
20 
(5/15) 
20.8 
Ling 
STb brackets (Ormco 
Corporation, Glendora, 
CA, USA) 
0.018”  Prefab 
NR (Max & 
Mand) 
Oral health parameters: DMFT, PI, GBI / 
salivary flow rate / salivary buffer capacity and 
pH / S. mutans count / Lactobacillus count 
(Bef-Tx, 0 wk, 4 wks, 8 wks) 
None; 
funded by 
research 
grant Lab 
(American Orthodontics, 
Sheboygan, Wisc; Roth 
prescription); 
0.018” Roth Prefab 
NR (Max & 
Mand) 
Rai 2013 
(32) 
pCCT; 
University; 
India 
12 (NR) NR 
Ling 
STb brackets (Ormco 
Corporation, Glendora, 
CA, USA) 
- - 
Prefab Indirect (Max & 
Mand) with 
TAD+BPD 
System® 
Objective, semiobjective, and subjective 
speech performance (Bef-Tx, 1 d, 1 wk, 1 mo) 
None 
Lab 
MBT Versatile+ brackets 
(3M Unitek, Monrovia, 
Calif) 
- MBT 
Prefab 
Direct (Max & 
Mand) 
Rai 2014 
(33) 
pCCT; 
University; 
India 
24 
(11/13) 
23.0 Ling 
STb brackets (Ormco 
Corporation, Glendora, 
CA, USA) 
- - 
Prefab Indirect (Max & 
Mand) with 
TAD+BPD 
System® 
Objective, semiobjective, and subjective 
speech performance (Bef-Tx, 1 d, 1 wk, 1 mo) 
None 
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Lab# 
MBT Versatile+ brackets 
(3M Unitek, Monrovia, 
Calif) 
- MBT 
Prefab 
Direct (Max & 
Mand) 
Shalish 
2012$ (34) 
pCCT 
University/pr
actices 
Israel 
47 
(18/29) 
NR 
Ling 
Incognito (3M-Unitek, 
Monrovia, Calif) 
0.018”  Indiv 
Indirect (Max & 
Mand) 
Pat-rep health-related quality of life using a 
Likert-scale / Pat-rep pain intensity and 
analgesic consumption / number of days 
needed to achieve mild or no pain (days 1-7 & 
day 14 after appliance insertion) 
Not 
mentioned 
Lab 
(GAC International, Inc., 
Bohemia NY, USA or 
Ormco, Glendora, CA, 
USA) 
0.022”  Prefab 
Direct (Max & 
Mand) 
Soldanova 
2011;2012 
(35, 36) 
pCCT 
University 
Czech 
Republic 
50 
(11/39) 
31.0 
Ling 
2D brackets (Forestadent, 
St Louis, Missouri, USA); 
NR  Prefab (Max & Mand) 
Treatment duration; Intercanine-, 
interpremolar-, intermolar width / arch length / 
cephalometric measurements for the sagittal 
and vertical position of the lower incisors (Bef-
Tx, Aft-Tx) 
No 
mention; 
funded by 
research 
grant 
Lab 
Minitrim brackets 
(Dentaurum, Ispringen, 
Germany 
0.018” Roth Prefab (Max & Mand) 
van der 
Veen 2010 
(37) 
split-mouth 
(Max-Mand) 
RCT 
practice 
Germany 
28 (NR) 15.3 
Ling 
Incognito (TOP Service 
for Lingualtechnik, Bad 
Essen, Germany) 
NR  Indiv 
Indirect (Max or 
Mand) Number of white spot lesions / (Bef-Tx, After-
Tx) 
Financial 
interest in 
product 
Lab 
Orthos (Ormco, 
Glendorra, CA, USA) 
NR  Prefab 
Direct (Max or 
Mand) 
Venkatesh 
2015@ (38) 
pCCT; 
University; 
India 
20 (NR) 20.0 
Ling 
STb brackets (Ormco 
Corporation, Glendora, 
CA, USA) 
0.018” MBT 
Prefab 
Indirect (Max & 
Mand) with 
TAD+BPD 
System® 
Cephalometric sagittal anchorage loss of the 
first maxillary permanent molar (before and 
after space closure) 
None 
Lab 
Victory brackets (3M 
Unitek, Monrovia, Calif) 
0.018” MBT 
Prefab Direct (Max & 
Mand) 
Wu 2010; 
2011 (39, 
40) 
pCCT 
University 
China 
60 
(20/40) 
21.0 
Ling 
Incognito (TOP Service 
for Lingualtechnik, Bad 
Essen, Germany) 
NR  Indiv 
Indirect (Max & 
Mand) 
Pat-rep pain experience / Pat-rep oral 
satisfaction: oral discomfort, mastication, 
speech disturbances, and social functioning 
using a VAS-scale / Pat-rep sleep disturbance, 
analgesic consumption, and timing of initial 
pain (1 wk, 1 mos, 3 mos) 
Not 
mentioned; 
funded by 
research 
grant 
Lab 
Mini-Diamond (Ormco, 
Orange, California, USA)  
NR  Prefab  
M/F, male/female; yrs, years; App, appliance; pCCT, prospective non-randomized clinical trial; Max, maxilla; Man, mandible; NR, not reported; TARG-TR, torque angulation reference guide + thickness 
& rotation; Pat-rep, patient-reported; mos, months; RCT, randomized controlled trial; Bef-Tx, before treatment; M1, first permanent molar; SS, stainless steel; DMFT, Decayed, missing, and filled teeth; 
PI, plaque index; GBI, gingival bleeding index; wk, week; Aft-Tx, after treatment; VAS, visual analogue scale. 
*lower arches in both LI and LA groups were treated with labial appliances. 
‡0.5-1.0mm bite-ramps on lower M1 
#Goshgarian transpalatal arch used on all patients with labial appliances  
@Nickel-Titanium closed coil spring and powerchains were used on the upper and lower dentition, respectively, for space closure 
$a third patient group treated with Invisalign is omitted. 
†all appliances were conventionally-ligated; not self-ligated. 
¥Including also data from communication with the trial’s authors. 
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Table 2 
Results of the performed meta-analyses 
Type Source Outcome (time) n Effect 95% CI P I2 
Discomfort Questionnaire Oral discomfort (0.5-3 months) 3 SMD=0.78 0.18,1.38* 0.012 7% (0%,75%) 
Speech Auditory analysis 
Upper boundary frequency of the /s/ sound in the middle of the 
word (after insertion) 
3 MD=-722.29 -1500.00,94.26** 0.083 97% (96%,68%) 
  Auditory analysis 
Upper boundary frequency of the /s/ sound in the middle of the 
word (1 week) 
2 MD=-312.18 -600.98,-23.39 0.034 75% (-) 
  Auditory analysis 
Upper boundary frequency of the /s/ sound in the middle of the 
word (1 month) 
3 MD=-441.12 -986.22,103.98*** 0.113 95% (90%,97%) 
  Auditory analysis 
Upper boundary frequency of the /s/ sound in the start of the 
word (after insertion) 
2 MD=-39.87 -195.65,115.91 0.616 0% (-) 
  Auditory analysis 
Upper boundary frequency of the /s/ sound in the start of the 
word (1 week) 
2 MD=-216.93 -372.62,-61.25 0.006 0% (-) 
  Auditory analysis 
Upper boundary frequency of the /s/ sound in the start of the 
word (1 month) 
2 MD=-120.22 -282.73,42.29 0.147 0% (-) 
  Clinical examination Speech performance by layperson (1 day) 2 MD=0.00 -0.22,0.21 0.989 - 
  Clinical examination Speech performance by layperson (1 week) 2 MD=0.82 0.58,1.05 <0.001 - 
  Clinical examination Speech performance by layperson (1 month) 2 MD=0.60 0.31,0.90 <0.001 30% (-) 
  Questionnaire Speech disturbance (3 months) 2 RR=8.9 1.15,68.69 0.036 0% (-) 
Eating Questionnaire Eating problems (3 months) 2 RR=5.35 0.97,29.50 0.054 0% (-) 
Dental 
effects 
Model analysis Intercanine width (after Tx) 2 MD=0.62 0.08,1.16 0.025 0% (-) 
  Model analysis Interpremolar width (after Tx) 2 MD=-1.47 -3.41,0.48 0.139 87% (-) 
  Model analysis Intermolar width (after Tx) 2 MD=-0.63 -2.45,1.19 0.499 86% (-) 
  Model analysis Arch length to molars (after Tx) 2 MD=-0.48 -1.75,0.79 0.461 70% (-) 
  
Cephalometric 
analysis 
Sagittal anchorage loss of the upper first molar (after Tx) 1 MD=-0.82 -1.09,-0.56 <0.001 - 
SMD, standarized mean differences; MD, mean differences; Tx, treatment; RR, relative risk. 
* with 95% predictive interval of -3.76 to 5.31. 
** with 95% predictive interval of -11163.32 Hz to 9718.14 Hz. 
*** with 95% predictive interval of -7367.05 Hz to 6484.81 Hz. 
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Table 3 
GRADE summary of findings table for the main outcomes of the systematic review 
Patients: receiving orthodontic treatment 
Settings: university clinics (Turkey, Syria, India, Czech Republic) 
Intervention: lingual fixed appliances 
Comparison: labial fixed appliances 
Outcomes 
Illustrative comparative effects (95% CI) Patients 
(trials) 
GRADE* Effect 
Labial appliances Lingual appliances   
 Assumed risk per 1000 patients † Corresponding risk per 1000 patients †    
Oral discomfort; patient-reported (0.5-3 
months) 
529 patient per 1000 
1648 more patients per 1000 
(204 to 5937 more) 
141 (3) 
Very low 
---- 
SMD=0.78 
(0.18,1.38); P<0.05 
 Assumed change Corresponding change    
Upper boundary frequency of the /s/ sound 
in the middle of the word; auditory analysis 
(1 month) 
The upper boundary frequency decreased 
on average by 61.51 Hz in the labial 
groups (range -1.27 Hz to -114.80 Hz) 
The mean upper boundary frequency in the lingual 
groups decreased by 441.12 Hz (95% CI: 986.22 Hz 
decrease to 103.98 Hz increase) compared to the 
labial groups. 
70 (3) 
Very low 
---- 
MD=-441.12 (-
986.22,103.98); 
P>0.05 
 Assumed change Corresponding change    
Speech performance; assessed by layperson 
on a 5-point Likert scale (5=worst) (1 
month) 
The Likert score decreased on average 
by 0.03 points in the labial groups (range 
-0.10 to 0.05 points) 
The mean Likert score in the lingual groups increased 
by 0.60 point (95% CI: 0.31 to 0.90 point increase) 
compared to the labial groups. 
36 (2) 
Very low 
---- 
MD=0.60 
(0.31,0.90); P<0.05 
 Assumed risk per 1000 patients Corresponding risk per 1000 patients    
Eating difficulty; patient-reported (3 months) 17 patient per 1000 (0 to 30) 
72 more patients per 1000 
(1 fewer to 475 more) 
94 (2) 
Very low 
---- 
RR=5.35 
(0.97,29.50); P>0.05 
 Assumed change Corresponding change    
Intercanine width; from dental cast analysis 
(after treatment) 
The intercanine width increased on 
average by 0.84 mm in the labial groups 
(range 0.37 mm to 1.30 mm) 
The mean intercanine width in the lingual groups 
increased by 0.62 mm (95% CI: 0.08 mm to 1.16 mm 
increase) compared to the labial groups. 
102 (2) 
Very low 
---- 
MD=0.62 
(0.08,1.16); P<0.05 
 Assumed change Corresponding change    
Intermolar width; from dental cast analysis 
(after treatment) 
The intermolar width increased on 
average by 0.48 mm in the labial groups 
(range 0.16 mm to 0.80 mm) 
The mean intermolar width in the lingual groups 
decreased by 0.63 mm (95% CI: 2.45 mm decrease to 
1.19 mm increase) compared to the labial groups. 
102 (2) 
Very low 
---- 
MD=-0.63 (-
2.45,1.19); P>0.05 
 Assumed change Corresponding change    
Sagittal anchorage loss of the upper first 
molar during space closure; cephalometric 
analysis (after treatment) 
The mean anchorage loss in the labial 
group was 2.06 mm. 
The mean anchorage loss in the lingual group 
decreased by 0.82 mm (95% CI: 0.56 mm to 1.09 mm 
decrease) compared to the labial group. 
20 (1) 
Very low 
---- 
MD=-0.82 (-1.09,-
0.56); P<0.05 
CI, confidence interval; SMD, standardized mean difference; MD, mean difference; RR, relative risk; Tx, treatment. 
†Assumed and corresponding changes calculated from the randomized trial of Khattab et al. (29), which was judged to be most robust. 
*All GRADE scores start from low, due to the inclusion of non-randomized trials and are further downgraded at least by one (see Appendix 6). 
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Fig. S1: Flow diagram for the identification and selection of studies 
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Fig. S2: Forest plot for the comparison of treatment effects from randomized and non-randomized trials. The difference in effects between randomized and non-randomized trials 
is expressed as difference in the standardized mean differences (ΔSMD) through random-effects meta-regression. Binary outcomes are appropriately converted to continuous and 
the ΔSMDs from all meta-analyses of Table S7 are pooled together with random-effects meta-analysis. RCT, randomized controlled trial; ΔSMD, as difference in the standardized 
mean differences; CI, confidence interval; D&L, DerSimonian & Laird method; UI, uncertainty interval.  
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Table S1 
The electronic databases searched, the search strategy used, and the corresponding results (as of July 20
th
, 2015) 
Database Search Strategy Limitations Hits 
MEDLINE 
searched through PubMed on July 20
th
, 2015 
http://www.ncbi.nlm.nih.gov/pubmed/ 
orthodon* AND (lingual OR Incognito OR Harmony OR Magic OR 
iBraces OR ―7th Generation‖ OR WIN OR STb OR 2D) AND labial 
AND (bracket* OR appliance*) 
Clinical Trial; Comparative Study; 
Controlled Clinical Trial; Randomized 
Controlled Trial; Humans 
57 
Cochrane Database of Systematic Reviews 
searched on July 20
th
, 2015 
http://onlinelibrary.wiley.com/cochranelibrary/search/ 
orthodon* AND (lingual OR Incognito OR Harmony OR Magic OR 
iBraces OR ―7th Generation‖ OR WIN OR STb OR 2D) AND labial 
AND (bracket* OR appliance*) 
- 1 
Database of Abstracts of Reviews of Effects 
searched on July 20
th
, 2015 
http://onlinelibrary.wiley.com/cochranelibrary/search/ 
orthodon* AND (lingual OR Incognito OR Harmony OR Magic OR 
iBraces OR ―7th Generation‖ OR WIN OR STb OR 2D) AND labial 
AND (bracket* OR appliance*) 
- 1 
Cochrane Central Register of Controlled Trials 
searched on July 20
th
, 2015 
http://onlinelibrary.wiley.com/cochranelibrary/search/ 
orthodon* AND (lingual OR Incognito OR Harmony OR Magic OR 
iBraces OR ―7th Generation‖ OR WIN OR STb OR 2D) AND labial 
AND (bracket* OR appliance*) 
- 10 
Virtual Health Library 
searched on July 20
th
, 2015 
http://regional.bvsalud.org/ 
orthodon* AND (lingual OR Incognito OR Harmony OR Magic OR 
iBraces OR ―7th Generation‖ OR WIN OR STb OR 2D) AND labial 
AND (bracket* OR appliance*) 
- 10 
Web of Science 
searched on July 20
th
, 2015 
https://isiknowledge.com/ 
orthodon* AND (lingual OR Incognito OR Harmony OR Magic OR 
iBraces OR ―7th Generation‖ OR WIN OR STb OR 2D) AND labial 
AND (bracket* OR appliance*) 
Dentistry, oral surgery, medicine 44 
Sum 123 
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Table S2 
List of included and excluded studies, with the corresponding reasons 
Paper Decision 
Almeida MR, Henriques JF, Almeida RR, Almeida-Pedrin RR, Ursi W. Treatment effects produced by 
the Bionator appliance. Comparison with an untreated Class II sample. Eur J Orthod 2004;26:65-72. 
Excluded by title 
Anehus-Pancherz M, Pancherz H. [The effect on chewing of treating distal bite with an activator]. J 
Orofac Orthop 1989;50:392-405. 
Excluded by title 
Atack N, Harradine N, Sandy JR, Ireland AJ. Which way forward? Fixed or removable lower retainers. 
Angle Orthod 2007;77:954-9. 
Excluded by title 
Atsu SS, Gelgor IE, Sahin V. Effects of silica coating and silane surface conditioning on the bond 
strength of metal and ceramic brackets to enamel. Angle Orthod 2006;76:857-62. 
Excluded by title 
Basciftci FA, Uysal T, Buyukerkmen A, Sari Z. The effects of activator treatment on the craniofacial 
structures of Class II division 1 patients. Eur J Orthod 2003;25:87-93. 
Excluded by title 
Carlstedt K, Henningsson G, Dahllof G. A four-year longitudinal study of palatal plate therapy in 
children with Down syndrome: effects on oral motor function, articulation and communication 
preferences. Acta Odontol Scand 2003;61:39-46. 
Excluded by title 
Carlstedt K, Henningsson G, McAllister A, Dahllof G. Long-term effects of palatal plate therapy on oral 
motor function in children with Down syndrome evaluated by video registration. Acta Odontol Scand 
2001;59:63-8. 
Excluded by title 
Chumak L, Galil KA, Way DC, Johnson LN, Hunter WS. An in vitro investigation of lingual bonding. 
Am J Orthod Dentofac Orthop 1989;95:20-8. 
Excluded by title 
De Almeida MR, Henriques JF, Ursi W. Comparative study of the Frankel (FR-2) and bionator 
appliances in the treatment of Class II malocclusion. Am J Orthod Dentofac Orthop 2002;121:458-66. 
Excluded by title 
de Cuebas JO. Nonsurgical treatment of a skeletal vertical discrepancy with a significant open bite. Am 
J Orthod Dentofac Orthop 1997;112:124-31. 
Excluded by title 
Dittmer MP, Demling AP, Borchers L, Stiesch M, Kohorst P, Schwestka-Polly R. Tensile properties of 
orthodontic elastomeric chains. J Orofac Orthop 2010;71:330-8. 
Excluded by title 
Farquhar RB. Direct bonding comparing a polyacrylic acid and a phosphoric acid technique. Am J 
Orthod Dentofac Orthop 1986;90:187-94. 
Excluded by title 
Fritz U, Diedrich P, Wiechmann D. Lingual technique--patients' characteristics, motivation and 
acceptance. Interpretation of a retrospective survey. J Orofac Orthop 2002;63:227-33. 
Excluded by title 
Gianelly AA. Leeway space and the resolution of crowding in the mixed dentition. Semin Orthod 
1995;1:188-94. 
Excluded by title 
Gisel EG, Schwartz S, Petryk A, Clarke D, Haberfellner H. "Whole body" mobility after one year of 
intraoral appliance therapy in children with cerebral palsy and moderate eating impairment. Dysphagia 
2000;15:226-35. 
Excluded by title 
Harazaki M, Isshiki Y. Soft laser irradiation effects on pain reduction in orthodontic treatment. The 
Bulletin of Tokyo Dental College 1997;38:291-5. 
Excluded by title 
Hohoff A, Ehmer U. Short-term and long-term results after early treatment with the Castillo Morales 
stimulating plate. A longitudinal study. J Orofac Orthop 1999;60:2-12. 
Excluded by title 
Honme Y, Motoyoshi M, Shinohara A, Shigeeda T, Shimizu N. Efficient palatal expansion with a 
quadhelix appliance: an in vitro study using an experimental dental arch model. Eur J Orthod 
2012;34:442-6. 
Excluded by title 
Jost-Brinkmann PG, Tanne K, Sakuda M, Miethke RR. [A FEM study for the biomechanical 
comparison of labial and palatal force application on the upper incisors. Finite element method]. J 
Orofac Orthop 1993;54:76-82. 
Excluded by title 
Kannabiran P, Thirukonda GJ, Mahendra L. The crown angulations and inclinations in Dravidian 
population with normal occlusion. Indian J Dent Res 2012;23:53-8. 
Excluded by title 
Kinzinger G, Fritz U, Diedrich P. Various anchorage approaches in unilateral mandibular molar 
distalization using a fixed lingual arch appliance. J Orofac Orthop 2004;65:137-49. 
Excluded by title 
Kravitz ND, Kusnoto B, BeGole E, Obrez A, Agran B. How well does Invisalign work? A prospective 
clinical study evaluating the efficacy of tooth movement with Invisalign. Am J Orthod Dentofac Orthop 
2009;135:27-35. 
Excluded by title 
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Liang W, Rong Q, Lin J, Xu B. Torque control of the maxillary incisors in lingual and labial 
orthodontics: a 3-dimensional finite element analysis. Am J Orthod Dentofac Orthop 2009;135:316-22. 
Excluded by title 
Lombardo L, Scuzzo G, Arreghini A, Gorgun O, Ortan YO, Siciliani G. 3D FEM comparison of lingual 
and labial orthodontics in en masse retraction. Prog Orthod 2014;15:38. 
Excluded by title 
Lombardo L, Stefanoni F, Mollica F, Laura A, Scuzzo G, Siciliani G. Three-dimensional finite-element 
analysis of a central lower incisor under labial and lingual loads. Prog Orthod 2012;13:154-63. 
Excluded by title 
Lombardo L, Wierusz W, Toscano D, Lapenta R, Kaplan A, Siciliani G. Frictional resistance exerted by 
different lingual and labial brackets: an in vitro study. Prog Orthod 2013;14:37. 
Excluded by title 
Matsuda A, Suda N, Motohashi N, Tsuji M, Ohyama K. Skeletal characteristics and treatment outcome 
of five patients with Robin sequence. Angle Orthod 2006;76:898-908. 
Excluded by title 
Moran KI. Relative wire stiffness due to lingual versus labial interbracket distance. Am J Orthod 
Dentofac Orthop 1987;92:24-32. 
Excluded by title 
Ngan P, Hagg U, Yiu C, Merwin D, Wei SH. Treatment response to maxillary expansion and 
protraction. Eur J Orthod 1996;18:151-68. 
Excluded by title 
Okay C, Gulsen A, Keykubat A, Ucem TT, Yuksel S. A comparison of the effects of 2 mandibular 
anchorage systems used with a 3-dimensional bimetric maxillary distalizing arch. World J Orthod 
2006;7:125-33. 
Excluded by title 
Opitz C, Muhler G, Bloch I, Schenk HJ. [A contribution to the controversial discussion on a 
preoperative orthodontic treatment for infants with unilateral cheilognathopalatoschisis]. J Orofac 
Orthop 1992;53:330-7. 
Excluded by title 
Ozturk Ortan Y, Yurdakuloglu Arslan T, Aydemir B. A comparative in vitro study of frictional 
resistance between lingual brackets and stainless steel archwires. Eur J Orthod 2012;34:119-25. 
Excluded by title 
Park JH, Lee YK, Lim BS, Kim CW. Frictional forces between lingual brackets and archwires measured 
by a friction tester. Angle Orthod 2004;74:816-24. 
Excluded by title 
Phillips C, Medland WH, Fields HW, Jr., Proffit WR, White RP, Jr. Stability of surgical maxillary 
expansion. Int J Adult Orthodon Orthognath Surg 1992;7:139-46. 
Excluded by title 
Quintao C, Helena I, Brunharo VP, Menezes RC, Almeida MA. Soft tissue facial profile changes 
following functional appliance therapy. Eur J Orthod 2006;28:35-41. 
Excluded by title 
Schuster G, Giese R. Retrospective clinical investigation of the impact of early treatment of children 
with Down's syndrome according to Castillo-Morales. J Orofac Orthop 2001;62:255-63. 
Excluded by title 
Showkatbakhsh R, Jamilian A, Taban T, Golrokh M. The effects of face mask and tongue appliance on 
maxillary deficiency in growing patients: a randomized clinical trial. Prog Orthod 2012;13:266-72. 
Excluded by title 
Sifakakis I, Pandis N, Makou M, Katsaros C, Eliades T, Bourauel C. A comparative assessment of 
forces and moments generated by lingual and conventional brackets. Eur J Orthod 2013;35:82-6. 
Excluded by title 
Smithpeter J, Covell D, Jr. Relapse of anterior open bites treated with orthodontic appliances with and 
without orofacial myofunctional therapy. Am J Orthod Dentofac Orthop 2010;137:605-14. 
Excluded by title 
So LL. Effects of reverse headgear treatment on sagittal correction in girls born with unilateral complete 
cleft lip and cleft palate--skeletal and dental changes. Am J Orthod Dentofac Orthop 1996;109:140-7. 
Excluded by title 
Sung SJ, Baik HS, Moon YS, Yu HS, Cho YS. A comparative evaluation of different compensating 
curves in the lingual and labial techniques using 3D FEM. Am J Orthod Dentofac Orthop 2003;123:441-
50. 
Excluded by title 
Wang B, Shen G, Fang B, Yu H, Wu Y, Sun L. Augmented corticotomy-assisted surgical orthodontics 
decompensates lower incisors in Class III malocclusion patients. J Oral Maxillofac Surg 2014;72:596-
602. 
Excluded by title 
Ahrens DG, Shapira Y, Kuftinec MM. An approach to rotational relapse. Am J Orthod 1981;80:83-91. Excluded by title 
Almeida MR, Henriques JF, Ursi W. Comparative study of the Fränkel (FR-2) and bionator appliances 
in the treatment of Class II malocclusion. Am J Orthod Dentofac Orthop 2002;5:458-66. 
Excluded by title 
Yu Y, Sun J, Lai W, Wu T, Koshy S, Shi Z. Interventions for managing relapse of the lower front teeth 
after orthodontic treatment. Cochrane Database Syst Rev 2013;9:CD008734. 
Excluded by title 
Atsü S, Çatalba, amp, Bülent, Gelgör IE. Effects of silica coating and silane surface conditioning on the 
bond strength of rebonded metal and ceramic brackets. J Appl Oral Sci 2011;19:233-9. 
Excluded by title 
Echarri P, Pedernera M. [Updated in the bracket positioning in the indirect bonding techniqueu]. 
Ortodoncia 2013;76:20-7. 
Excluded by title 
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Menezes CCd. [Labial movement of the mandibular incisors and tomographic characteristics of the 
labial and lingual alveolar bone]. 2014; Doctoral thesis, Faculdade de Odontologia de Bauru. 
Excluded by title 
Piacenza A, Mondino N. [Another alternative in orthodontics. Spring retainers (elastic retainer)]. Claves 
Odontol 1995;2:8-9. 
Excluded by title 
Reis AC, Capelozza Filho L, Ozawa TO, Cavassan AdO. [Evaluation of tipping and inclination of teeth 
in young adults with complete bilateral cleft lip and palate]. Rev Dent Press Ortodon Ortopedi Facial 
2008;13:113-23. 
Excluded by title 
Rothier EKC, Vilella OdV. [Technique to make temporary esthetic pontics for orthodontic appliances]. 
Rev Bras Odontol 2012;69:258-9. 
Excluded by title 
Chung K-R, Kim S-H, Lee B-S. Speedy surgical-orthodontic treatment with temporary anchorage 
devices as an alternative to orthognathic surgery. Am J Orthod Dentofacial Orthop 2009;135:787-98. 
Excluded by title 
Chung K-R, Kook Y-A, Kim S-H, Mo S-S, Jung J-A. Class II malocclusion treated by combining a 
lingual retractor and a palatal plate. Am J Orthod Dentofacial Orthop 2008;133:112-23. 
Excluded by title 
Geron S, Shpack N, Kandos S, Davidovitch M, Vardimon AD. Anchorage loss - A multifactorial 
response. Angle Orthod 2003;73:730-7. 
Excluded by title; known to be 
retrospective 
Janson G, de Souza JEP, Alves FD, Andrade P, Nakamura A, de Freitas MR, et al. Extreme 
dentoalveolar compensation in the treatment of Class III malocclusion. Am J Orthod Dentofacial Orthop 
2005;128:787-94. 
Excluded by title 
Kawakami M, Miyawaki S, Noguchi H, Kirita T. Screw-type implants used as anchorage for lingual 
orthodontic mechanics: A case of bimaxillary protrusion with second premolar extraction. Angle Orthod 
2004;74:715-9. 
Excluded by title 
Levin L, Samorodnitzky-Naveh GR, Machtei EE. The Association of Orthodontic Treatment and Fixed 
Retainers With Gingival Health. J Periodontol 2008;79:2087-92. 
Excluded by title 
Matsuda A, Suda N, Motohashi N, Tsuji M, Ohyama K. Skeletal characteristics and treatment outcome 
of five patients with Robin sequence cases. Angle Orthod 2006;76:898-908. 
Excluded by title 
Miyawaki S, Yasuhara M, Koh Y. Discomfort caused by bonded lingual orthodontic appliances in adult 
patients as examined by retrospective questionnaire. Am J Orthod Dentofacial Orthop 1999;115:83-8. 
Excluded by title 
Mo S-S, Kim S-H, Sung S-J, Chung K-R, Chun Y-S, Kook Y-A, et al. Factors controlling anterior 
torque during C-implant-dependent en-masse retraction without posterior appliances. Am J Orthod 
Dentofacial Orthop 2011;140:72-80. 
Excluded by title 
Nihara J, Gielo-Perczak K, Cardinal L, Saito I, Nanda R, Uribe F. Finite element analysis of mandibular 
molar protraction mechanics using miniscrews. Eur J Orthod 2015;37:95-100. 
Excluded by title 
Oesterle LJ, Shellhart WC. Bracket bond strength with transillumination of a light-activated orthodontic 
adhesive. Angle Orthod 2001;71:307-11. 
Excluded by title 
Phan X, Ling PH. Clinical limitations of invisalign. J Can Dent Assoc 2007;73:263-6. Excluded by title 
Wahl N. Orthodontics in 3 millennia. Chapter 16: Late 20th-century fixed appliances. Am J Orthod 
Dentofacial Orthop 2008;134:827-30. 
Excluded by title 
Wehrbein H, Bauer W, Diedrich P. Mandibular incisors alveolar bone, and symphysis after orthodontic 
treatment. A retrospective study. Am J Orthod Dentofacial Orthop 1996;110:239-46. 
Excluded by title 
Wiechmann D, Schwestka-Polly R, Hohoff A. Herbst appliance in lingual orthodontics. Am J Orthod 
Dentofacial Orthop 2008;134:439-46. 
Excluded by title 
Yanagita T, Nakamura M, Kawanabe N, Yamashiro T. Class II malocclusion with complex problems 
treated with a novel combination of lingual orthodontic appliances and lingual arches. Am J Orthod 
Dentofacial Orthop 2014;146:98-107. 
Excluded by title 
Kim SH, Park SB, Yang HC. Three-dimensional finite element analysis of the bracket positioning plane 
in lingual orthodontics. Korean J Orthod 2006;36:30-44. 
Excluded by title 
Mah YJ, Sohn H-K, Choi B-J, Lee J-H, Kim SO. Orthodontic traction of horizontally erupted lower 
lateral incisor on the lingual side. J Korean Acad Pediatr Dent 2010;37:117-23. 
Excluded by title 
Demling A, Dittmer MP, Schwestka-Polly R. Comparative analysis of slot dimension in lingual bracket 
systems. Head Face Med 2009;5:27. 
Excluded by abstract; not a 
clinical study 
Fuck LM, Wiechmann D, Drescher D. Comparison of the initial orthodontic force systems produced by 
a new lingual bracket system and a straight-wire appliance. J Orofac Orthop 2005;66:363-76. 
Excluded by abstract; not a 
clinical study 
Hugo A, Reyneke JP, Weber ZJ. Lingual orthodontics and orthognathic surgery. Int J Adult Orthodon 
Orthognath Surg 2000;15:153-62. 
Excluded by abstract; not a 
clinical study 
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Shpack N, Geron S, Floris I, Davidovitch M, Brosh T, Vardimon AD. Bracket placement in lingual vs 
labial systems and direct vs indirect bonding. Angle Orthod 2007;77:509-17. 
Excluded by abstract; not a 
clinical study 
Ugur T, Yukay F. Normal faciolingual inclinations of tooth crowns compared with treatment groups of 
standard and pretorqued brackets. Am J Orthod Dentofac Orthop 1997;112:50-7. 
Excluded by abstract; not a 
clinical study 
Long H, Zhou Y, Pyakurel U, Liao L, Jian F, Xue J, Ye N, Yang X, Wang Y, Lai W. Comparison of 
adverse effects between lingual and labial orthodontic treatment. Angle Orthod 2013;83:1066-73. 
Excluded by abstract; not a 
clinical study 
Echarri P. [Correction of the anterior deep bite and anterior open bite with the double-arch technique 
and with labial or lingual brackets]. Ortod Esp 2003;43:240-51. 
Excluded by abstract; not a 
clinical study 
Galvão MCdS, Maltagliati LÁ, Sannomiya EK, Bommarito S. [Discomfort caused by lingual 
orthodontic appliance bonding versus labial]. Ortodontia 2008;41:19-24. 
Excluded by abstract; not a 
clinical study 
Monini AdC, Gandini Júnior LG, Gandini MREAS, Figueiredo JFBd. [Biomechanical differences 
between lingual and labial orthodontics]. Rev Dent Press Ortodon Ortopedi Facial 2008;13:92-100. 
Excluded by abstract; not a 
clinical study 
Geron S, Romano R, Brosh T. Vertical forces in labial and lingual orthodontics applied on maxillary 
incisors - A theoretical approach. Angle Orthod 2004;74:195-201. 
Excluded by abstract; not a 
clinical study 
Major TW, Carey JP, Nobes DS, Heo G, Melenka GW, Major PW. An investigation into the mechanical 
characteristics of select self-ligated brackets at a series of clinically relevant maximum torquing angles: 
loading and unloading curves and bracket deformation. Eur J Orthod 2013;35:719-29. 
Excluded by abstract; not a 
clinical study 
Looi LK, Mills JR. The effect of two contrasting forms of orthodontic treatment on the facial profile. 
Am J Orthod 1986;89:507-17. 
Excluded by abstract; no 
lingual appliances 
Lossdoerfer S, Schwestka-Polly R, Wiechmann D. Control of lower incisor inclination with a 
completely customized lingual appliance for dentoalveolar compensation of class III malocclusion. J 
Orofac Orthop 2013;74:381-96. 
Excluded by abstract; lingual 
appliances not compared to 
labial appliances 
Dalessandri D, Lazzaroni E, Migliorati M, Piancino MG, Tonni I, Bonetti S. Self-ligating fully 
customized lingual appliance and chair-time reduction: a typodont study followed by a randomized 
clinical trial. Eur J Orthod 2013;35:758-65. 
Excluded by full-text; lingual 
appliances not compared to 
labial appliances 
Demling A, Demling C, Schwestka-Polly R, Stiesch M, Heuer W. Short-term influence of lingual 
orthodontic therapy on microbial parameters and periodontal status. A preliminary study. Angle Orthod 
2010;80:480-4. 
Excluded by full-text; lingual 
appliances not compared to 
labial appliances 
Sfondrini MF, Debiaggi M, Zara F, Brerra R, Comelli M, Bianchi M, Pollone SR, Scribante A. 
Influence of lingual bracket position on microbial and periodontal parameters in vivo. J Appl Oral Sci 
2012;20:357-61. 
Excluded by full-text; partial 
fixed-appliance (brackets only 
on selected teeth and no wire) 
Deguchi T, Terao F, Aonuma T, Kataoka T, Sugawara Y, Yamashiro T, et al. Outcome assessment of 
lingual and labial appliances compared with cephalometric analysis, peer assessment rating, and 
objective grading system in Angle Class II extraction cases. Angle Orthod 2015;85:400-7. 
Excluded by full-text; 
retrospective clinical trial 
Gorman JC, Smith RJ. Comparison of treatment effects with labial and lingual fixed appliances. Am J 
Orthod Dentofac Orthop 1991;99:202-9. 
Excluded by full-text; 
retrospective clinical trial 
Caniklioglu C, Ozturk Y. Patient discomfort: a comparison between lingual and labial fixed appliances. 
Angle Orthod 2005;75:86-91. 
Included 
Khattab TZ, Farah H, Al-Sabbagh R, Hajeer MY, Haj-Hamed Y. Speech performance and oral 
impairments with lingual and labial orthodontic appliances in the first stage of fixed treatment. Angle 
Orthod 2013;83:519-26. 
Included 
Khattab TZ, Hajeer MY, Farah H, Al-Sabbagh R. Maxillary dental arch changes following the leveling 
and alignment stage with lingual and labial orthodontic appliances: a preliminary report of a randomized 
controlled trial. J Contemp Dent Pract 2014;15:561-6. 
Included 
Lombardo L, Ortan YO, Gorgun O, Panza C, Scuzzo G, Siciliani G. Changes in the oral environment 
after placement of lingual and labial orthodontic appliances. Prog Orthod 2013;14:28. 
Included 
Rai AK, Ganeshkar SV, Rozario JE. Parametric and nonparametric assessment of speech changes in 
labial and lingual orthodontics: A prospective study. APOS Trends Orthod 2013;3:99-109. 
Included 
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Rai AK, Rozario JE, Ganeshkar SV. Comparison of speech performance in labial and lingual 
orthodontic patients: A prospective study. Dent Res J (Isfahan) 2014;11:663-675. 
Included 
Shalish M, Cooper-Kazaz R, Ivgi I, Canetti L, Tsur B, Bachar E, et al. Adult patients' adjustability to 
orthodontic appliances. Part I: a comparison between Labial, Lingual, and Invisalign. Eur J Orthod 
2012;34:724-30. 
Included 
Soldanova M. [Comparison of treatment effectiveness lingual apparatus 2D and apparatus straight wire]. 
Master Thesis, 2011, Palacký University, Olomouc, Czech Republic. 
Included 
Soldanova M, Leseticky O, Komarkova L, Dostalova T, Smutny V, Spidlen M. Effectiveness of 
treatment of adult patients with the straightwire technique and the lingual two-dimensional appliance. 
Eur J Orthod 2012;34:674-80. 
Included 
van der Veen MH, Attin R, Schwestka-Polly R, Wiechmann D. Caries outcomes after orthodontic 
treatment with fixed appliances: do lingual brackets make a difference? Eur J Oral Sci 2010;118:298-
303. 
Included 
Venkatesh S, Rozario J, Ganeshkar SV, Ajmera S. Comparative evaluation of sagittal anchorage loss in 
lingual and labial appliances during space closure: A pilot study. APOS Trends Orthod 2015;5:33-7. 
Included 
Wu A, McGrath C, Wong RW, Wiechmann D, Rabie AB. Comparison of oral impacts experienced by 
patients treated with labial or customized lingual fixed orthodontic appliances. Am J Orthod Dentofac 
Orthop 2011;139:784-90. 
Included 
Wu AK, McGrath C, Wong RW, Wiechmann D, Rabie AB. A comparison of pain experienced by 
patients treated with labial and lingual orthodontic appliances. Eur J Orthod 2010;32:403-7. 
Included 
.
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Table S3 
Additional characteristics of the included trials (supplemental to Table 1) 
Trial Inclusion criteria Wires for lingual group Wires for labial group Sample size justified 
 
Caniklioglu 
2005 
NR 0.43mm x 0.43mm CuNiTi 0.43mm x 0.43mm CuNiTi 
No sample size 
calculation 
Pat-rep problems: 
discomfort/ tongue-lip-cheek 
soreness/ eating, speech, and 
oral care difficulties/ 
adaptation period/ general 
problems (3 mos) 
Khattab 2013
¥
 
Class I division 1; 15-30 years; full permanent dentition; 
moderate upper anterior crowding, indicated for non-
extraction treatment; no crossbites; no syndromes; no cleft lip 
palate; no speech or hearing disorder; no previous orthodontic 
treatment 
0.30mm CuNiTi 
(individualized; Forestadent®, 
Germany) 
0.30mm CuNiTi 
(prefabricated; Ormco, 
Sybron Dental Specialties, 
Orange, Calif)  
Sample size 
calculated a priori 
Speech performance 
evaluated with auditive 
analysis / Pat-rep oral 
impairment using a Likert-
scale: oral discomfort, 
speech impairment, 
mastication difficulties (Bef-
Tx, 1 mo, 3 mos) 
Khattab 2014
¥
 
Class I division 1; 15-30 years; full permanent dentition; 
moderate upper anterior crowding, indicated for non-
extraction treatment; no crossbites 
0.30mm NiTi-0.36mm NiTi-
0.41mm CuNiTi 
(individualized using Template 
for Biolingual® arches, 
Forestadent®, Germany) 
0.30mm NiTi-0.36mm 
NiTi-0.41mm CuNiTi 
(prefabricated Ormco, 
Sybron Dental Specialties, 
Orange, Calif) 
Sample size 
calculated (probably 
a priori) 
Intercanine-/ interpremolar-/ 
intermolar width; arch 
length; amount of enamel 
reduction (Bef-Tx, after 
leveling/aligning) 
Lombardo 
2013 
Class I non-extraction patients; 19-23 years; permanent 
dentition; no caries; no demineralization; no periodontal 
disease; no antibiotic or antibacterial mouthwash; no systemic 
disease 
NR NR 
No sample size 
calculation 
Oral health parameters: 
DMFT, PI, GBI / salivary 
flow rate / salivary buffer 
capacity and pH / S. mutans 
count / Lactobacillus count 
(Bef-Tx, 0 wk, 4 wks, 8 wks) 
Rai 2013 
Native speakers; 18-35 years; no CLP, no speech or hearing 
disorders; no previous speech therapy 
NR NR 
No sample size 
calculation 
Objective, semiobjective, 
and subjective speech 
performance (Bef-Tx, 1 d, 1 
wk, 1 mo) 
Rai 2014 
Native speakers; 18-35 years; moderate crowding; no CLP; 
no speech or hearing disorders; no previous speech therapy 
NR NR 
No sample size 
calculation 
Objective, semiobjective, 
and subjective speech 
performance (Bef-Tx, 1 d, 1 
wk, 1 mo) 
Shalish 2012$ Adult patients; 18-60 years 0.36mm NiTi 0.36mm NiTi No sample size Pat-rep health-related quality 
8 
 
calculation of life using a Likert-scale / 
Pat-rep pain intensity and 
analgesic consumption / 
number of days needed to 
achieve mild or no pain 
(days 1-7 & day 14 after 
appliance insertion) 
Soldanova 
2011; 2012 
Class I patients with crowding, indicated for non-extraction 
treatment; completed dental growth 
prefabricated 0.30mm NiTi-
0.36mm NiTi-0.41mm NiTi-
0.41mm SS 
Prefabricated 0.30mm 
NiTi-0.41mm NiTi-
0.43mm x 0.51mm NiTi-
0.41mm x 0.56mm SS 
No sample size 
calculation 
Treatment duration; 
Intercanine-, interpremolar-, 
intermolar width / arch 
length / cephalometric 
measurements for the sagittal 
and vertical position of the 
lower incisors (Bef-Tx, Aft-
Tx) 
van der Veen 
2010 
12-18 years; good health; no caries; no demineralizations; 
fully erupted premolars and canines 
NR NR 
Sample size 
calculated (probably 
a priori) 
Number of white spot lesions 
/ (Bef-Tx, After-Tx) 
Venkatesh 
2015 
Bimaxillary dentoalveolar protrusion with planned extraction 
of upper first premolars; permanent dentition (excluding 
second-third molars); critical anchorage cases needing 75%-
100% anterior retraction; medium-angle cases; no deepbite 
(no bite ramps should be needed); no severe crowding; no 
systemic diseases; no syndromes; no Class II or Class III 
Prefabricated 0.30mm NiTi-
0.36mm NiTi-0.41mm NiTi-
0.41mm or 0.46mm SS-
0.43mm x 0.51mm TMA 
Prefabricated 0.30mm 
NiTi-0.36mm NiTi-
0.41mm NiTi-0.41mm or 
0.46mm SS-0.43mm x 
0.51mm SS 
No sample size 
calculation 
Cephalometric sagittal 
anchorage loss of the first 
maxillary permanent molar 
(before and after space 
closure) 
Wu 2010; 2011 NR NR NR 
No sample size 
calculation 
Pat-rep pain experience / Pat-
rep oral satisfaction: oral 
discomfort, mastication, 
speech disturbances, and 
social functioning using a 
VAS-scale / Pat-rep sleep 
disturbance, analgesic 
consumption, and timing of 
initial pain (1 wk, 1 mos, 3 
mos) 
NR, not reported; CuNiTi, copper-nickel-titanium; Pat-rep, patient-reported; mos, months; Bef-Tx, before treatment; DMFT, Decayed, missing, and filled teeth; PI, plaque index; GBI, 
gingival bleeding index; NiTi, nickel-titanium; SS, stainless steel.wk, week; Aft-Tx, after treatment; VAS, visual analogue scale. 
$ a third patient group treated with Invisalign is omitted. 
¥
 Including also data from communication with the trial’s authors. 
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Table S4 
Detailed risk of bias assessment for the included trials 
Trial Sequence generation Allocation concealment 
Blinding of participants, 
personnel 
Blinding of outcome assessors 
Incomplete outcome 
data 
Selective outcome reporting 
Other sources of 
bias 
Caniklio
glu 2005 
High risk - no mention of 
random allocation throughout 
the paper and highly 
improbable that it took place: 
"These patients were divided 
into two groups". 
Unclear - no mention throughout the paper; highly 
improbable that allocation was concealed. 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
High risk - no mention of blinding 
throughout the paper; blinding is practical 
only for the person responsible for reading 
the discomfort questionnaires. 
Low risk - No drop-outs 
or patient losses are 
reported. 
Unclear - It is difficult to 
judge whether selective 
reporting is a problem, as 
no protocol exists. 
Unclear - residual 
bias cannot be 
excluded. 
Khattab 
2013 
Low risk - " patient assignment 
was based on computer-
generated random numbers" 
Unclear - allocation concealment probably 
conducted, but proper description is missing: 
"allocation procedure was concealed from the 
researcher and was conducted by one of the co-
authors" 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
High risk - no mention of blinding 
throughout the paper; blinding should be 
possible. 
Low risk - No drop-outs 
or patient losses. 
Low risk - No protocol exist 
for the trial. However, 
given the very specific 
outcome that the trial was 
based upon, which is fully 
reported, it is improbable 
that selective reporting 
exists. 
Low risk - no 
additional sources 
of bias identified. 
Khattab 
2014 
Low risk - "He created a 
randomization list using 
Minitab® V.15 with an 
allocation ratio of 1:1". 
Low risk - allocation sequence fully concealed: 
"The allocation sequence was concealed from the 
principal researcher (TK) enrolling and assessing 
participants in sequentially numbered opaque and 
sealed envelopes. To prevent subversion of the 
allocation sequence, the name and the date of birth 
of each participant was written on the envelope 
and these data were transferred onto the allocation 
card inside each envelope. Corresponding 
envelopes were opened only after completing all 
baseline assessments and the time came to allocate 
the intervention" 
Low risk - blinding is 
impractical for both 
patient and clinician; 
however, authors went to 
great extent to blind the 
outcome assessment, 
which was objective in 
nature. 
Low risk - blinding of outcome assessment 
adequate: "Blinding of study models to 
avoid assessor’s bias was based on 
trimming off the brackets from the lingual 
surfaces of upper teeth on the study models 
of patients in the lingual group...The 
opposite procedure was performed for study 
models belonging to the labial group. Great 
care was given to make both surfaces of 
each tooth alike in terms of coarseness. " 
Unclear - The authors 
report that 58 patients 
were finally considered 
for randomization, but 
only 52 patients are 
analyzed in the end. 
Unclear - It is difficult to 
judge whether selective 
reporting is a problem, as 
no protocol could be found. 
High risk – bias 
might have been 
introduced in the 
primary outcome 
(arch dimensions) 
due to archwire 
differences (wires 
were individualized 
only in the lingual 
group) and due to 
differences in the 
amount of enamel 
removed. 
Lombar
do 2013 
Unclear - randomization 
description inadequate: "The 
20 non-extraction class I 
patients were randomly di-
vided into two experimental 
groups" 
Unclear - no mention throughout the paper. 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
High risk - no mention of blinding 
throughout the paper; blinding should be 
possible. 
Low risk - No drop-outs 
or patient losses are 
reported. 
Unclear - It is difficult to 
judge whether selective 
reporting is a problem, as 
no protocol exists. 
Unclear - residual 
bias cannot be 
excluded. 
Rai 
2013 
High risk - no mention of 
random allocation throughout 
the paper and highly 
improbable that it took place: 
"The subjects were assigned 
two different groups — Li 
(lingual) and La (labial).". 
Unclear - no mention throughout the paper. 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
Unclear – No blinding mentioned, but 
speech pathologists’ assessment (semi-
objective) was judged as semi-masked: Two 
clinical judges trained in speech pathology 
listened independently to the recording of 
59 words, played in a random manner that 
prevented identification of patients or 
treatment periods. The same applied for the 
subjective assessment. 
Low risk - No drop-outs 
or patient losses are 
reported. 
Unclear - It is difficult to 
judge whether selective 
reporting is a problem, as 
no protocol exists. 
Unclear - residual 
bias cannot be 
excluded. 
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Rai 
2014 
High risk - no mention of 
random allocation throughout 
the paper and highly 
improbable that it took place: 
"The subjects were assigned 
two different groups — Li 
(lingual) and La (labial).". 
Unclear - no mention throughout the paper. 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
Low risk – The semi-objective and the 
subjective speech assessment was reported 
to be blind. We judged that similar 
measures were taken also for the objective 
speech assessment. 
Low risk - No drop-outs 
or patient losses are 
reported. 
Unclear - It is difficult to 
judge whether selective 
reporting is a problem, as 
no protocol exists. 
Unclear - residual 
bias cannot be 
excluded. 
Shalish 
2012 
High risk - no mention of 
random allocation throughout 
the paper and highly 
improbable that it took place. 
Unclear - no mention throughout the paper; highly 
improbable that allocation was concealed. 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
High risk - no mention of blinding 
throughout the paper; blinding is practical 
only for the person responsible for reading 
the discomfort questionnaires . 
Low risk - No drop-outs 
or patient losses are 
reported. 
High risk - recovery time 
not reported in adequate 
detail. Outcomes from the 
questionnaire missing from 
the report. 
Unclear - residual 
bias cannot be 
excluded. 
Soldano
va 2011; 
2012 
High risk - no mention of 
random allocation throughout 
the paper and highly 
improbable that it took place: 
"These patients were divided 
into two equal-sized groups 
according to aesthetic demands 
of treatment" 
Unclear - no mention throughout the paper; highly 
improbable that allocation was concealed. 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
High risk - no mention of blinding 
throughout the paper; blinding could have 
been implemented. 
Low risk - No drop-outs 
or patient losses are 
reported. 
Unclear - It is difficult to 
judge whether selective 
reporting is a problem, as 
no protocol exists. Included 
outcomes reported in 
sufficient detail. 
Unclear - residual 
bias cannot be 
excluded. 
Differences in 
archwire might also 
introduce bias. 
van der 
Veen 
2010 
Unclear - randomization 
description inadequate: 
"Subjects were randomly 
appointed to one of two 
groups" 
Unclear - no mention throughout the paper. 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
High risk - no mention of blinding 
throughout the paper; blinding could have 
been implemented. 
High risk – Early 
debracketing of eight 
patients and two cases 
of bracket failure, which 
were not taken into 
account in the analyses. 
High risk - It is difficult to 
judge whether selective 
reporting is a problem, as 
no protocol exists. Included 
outcome about QLF not 
reported in sufficient detail. 
Unclear - residual 
bias cannot be 
excluded. 
Venkate
sh 2015 
High risk - no mention of 
random allocation throughout 
the paper and highly 
improbable that it took place: 
"The subjects were assigned 
two different groups — Li 
(lingual) and La (labial).". 
Unclear - no mention throughout the paper. 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
High risk – No blinding mentioned, 
although it was feasible. 
Low risk - No drop-outs 
or patient losses are 
reported. 
Unclear - It is difficult to 
judge whether selective 
reporting is a problem, as 
no protocol exists. 
Unclear - residual 
bias cannot be 
excluded. 
Wu 
2010; 
2011 
High risk - no mention of 
random allocation throughout 
the paper and highly 
improbable that it took place. 
Unclear - no mention throughout the paper; highly 
improbable that allocation was concealed. 
Unclear - no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
High risk - no mention of blinding 
throughout the paper; blinding could have 
been implemented. 
Low risk - No drop-outs 
or patient losses are 
reported. 
High risk - outcomes not 
reported in adequate detail. 
Unclear - residual 
bias cannot be 
excluded. 
. 
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Table S5 
Results of individual included trials and performed meta-analyses 
Type Source Outcome Studies† Effect 95% CI P I2(%) 
Hygiene & soft/hard 
tissues  
Quest Oral hygiene problems (3 months) 1a RR=1.40 0.91,2.15 0.123 - 
 Quest 
Oral hygiene problems: high intensity (3 
months) 
1a RR=0.24 0.01,5.57 0.376 - 
 Quest 
Oral hygiene problem: food impaction (3 
months) 
1a RR=1.25 1.03,1.50 0.022 - 
 Quest 
Oral hygiene problem: bleeding gum (3 
months) 
1a RR=1.38 0.65,2.93 0.410 - 
 Quest Oral hygiene problem: bad taste (3 months) 1a RR=1.40 0.50,3.92 0.522 - 
 Clin. Plaque index (1 month) 1d MD=-0.01 -0.14,0.12 0.879 - 
 Clin. Plaque index (2 months) 1
d MD=0.11 0.00,0.22 0.049 - 
 Clin. Gingival bleeding index (1 month) 1
d MD=-0.10 -0.20,0.00 0.057 - 
 Clin. Gingival bleeding index (2 months) 1
d MD=0.09 -0.03,0.21 0.136 - 
 Clin./Lab. Salivary flow rate (1 month) 1
d MD=-0.12 -0.45,0.21 0.474 - 
 Clin./Lab. Salivary flow rate (2 months) 1
d MD=-0.16 -0.73,0.41 0.579 - 
 Clin./Lab. Salivary buffering capacity (1 month) 1
d MD=-0.30 -0.80,0.20 0.235 - 
 Clin./Lab. Salivary buffering capacity (2 months) 1
d MD=-0.35 -0.76,0.06 0.097 - 
 Clin./Lab. S. mutans high count (1 month) 1
d RR=1.00 0.65,1.55 1.000 - 
 Clin./Lab. S. mutans high count (3 months) 1
d RR=1.13 0.78,1.63 0.535 - 
 Clin./Lab. Lactobacillus high count (1 month) 1
d RR=2.00 0.68,5.85 0.206 - 
 Clin./Lab. Lactobacillus high count (3 months) 1
d RR=1.50 0.60,3.74 0.384 - 
 Clin. 
Number of new WSL per jaw 
(univariable*) 
1i IRR=0.21 0.08,0.59 0.003 - 
 Clin. 
Number of new WSL per jaw 
(multivariable*) 
1i IRR=0.28 0.10,0.73 0.010 - 
 Clin. 
Sum of change in F per jaw lesions 
(univariable*) 
1i IRR=0.27 0.02,3.22 0.302 - 
 Clin. 
Sum of change in F per jaw lesions 
(multivariable*) 
1i IRR=0.33 0.03,4.14 0.390 - 
 Clin. 
Sum of change in Q per jaw lesions 
(univariable*) 
1i IRR=0.07 0.01,0.79 0.032 - 
 Clin. 
Sum of change in Q per jaw lesions 
(multivariable*) 
1i IRR=0.07 0.01,0.69 0.023 - 
 Clin. 
Sum of change in lesion area per jaw 
lesions (univariable*) 
1i IRR=0.06 0.00,0.82 0.035 - 
 Clin. 
Sum of change in lesion area per jaw 
lesions (multivariable*) 
1i IRR=0.13 0.01,1.70 0.121 - 
 Clin. 
Incidence of new WSL per jaw 
(univariable*) 
1i OR=0.35 0.10,1.22 0.099 - 
 Clin. 
Incidence of new WSL per jaw 
(multivariable*) 
1i OR=0.43 0.11,1.61 0.209 - 
        
Discomfort Quest Oral discomfort (0.5-3 months) 3abg SMD=0.78 0.18,1.38 0.012 7 
 Quest Oral discomfort: generalized (3 months) 1a RR=1.45 0.46,4.61 0.529 - 
 Quest Oral discomfort: high intensity (3 months) 1a RR=2.09 0.92,4.76 0.078 - 
 Quest Tongue discomfort (3 months) 1a RR=3.38 1.84,6.18 <0.001 - 
 Quest 
Tongue discomfort: high intensity (3 
months) 
1a RR=10.61 0.71,159.64 0.088 - 
 Quest 
Tongue discomfort: duration longer than 
30 days (3 months) 
1a RR=0.96 0.04,21.65 0.982 - 
 Quest Cheeks discomfort (3 months) 1a RR=0.42 0.26,0.69 0.001 - 
 Quest 
Cheeks discomfort: high intensity (3 
months) 
1a RR=0.79 0.09,6.77 0.828 - 
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 Quest 
Cheeks discomfort: duration longer than 30 
days (3 months) 
1a RR=0.25 0.02,4.29 0.339 - 
 Quest Lips discomfort (3 months) 1a RR=0.36 0.15,0.87 0.023 - 
 Quest Lips discomfort: high intensity 1a RR=7.50 0.35,159.54 0.196 - 
 Quest 
Lips discomfort: duration longer than 30 
days 
1a RR=NE   - 
 Quest Oral pain in VAS scale (1 day) 1g MD=0.75 -0.95,2.45 0.387 - 
 Quest Oral pain in VAS scale (2 days) 1g MD=1.86 0.02,3.71 0.048 - 
 Quest Oral pain in VAS scale (3 days) 1g MD=1.86 0.04,3.68 0.045 - 
 Quest Oral pain in VAS scale (4 days) 1g MD=1.78 0.11,3.45 0.036 - 
 Quest Oral pain in VAS scale (5 days) 1g MD=1.61 0.12,3.10 0.034 - 
 Quest Oral pain in VAS scale (6 days) 1g MD=2.11 0.64,3.58 0.005 - 
 Quest Oral pain in VAS scale (7 days) 1g MD=1.61 0.37,2.85 0.011 - 
 Quest Oral pain in VAS scale (14 days) 1g MD=1.19 0.27,2.11 0.012 - 
 Quest Oral discomfort in Likert scale (1 day) 1g MD=0.49 -0.09,1.07 0.098 - 
 Quest Oral discomfort in Likert scale (2 days) 1g MD=0.86 0.22,1.50 0.008 - 
 Quest Oral discomfort in Likert scale (3 days) 1g MD=0.92 0.29,1.55 0.004 - 
 Quest Oral discomfort in Likert scale (4 days) 1g MD=0.82 0.27,1.37 0.003 - 
 Quest Oral discomfort in Likert scale (5 days) 1g MD=0.69 0.19,1.19 0.007 - 
 Quest Oral discomfort in Likert scale (6 days) 1g MD=0.84 0.34,1.34 0.001 - 
 Quest Oral discomfort in Likert scale (7 days) 1g MD=0.67 0.26,1.08 0.001 - 
 Quest Oral discomfort in Likert scale (14 days) 1g MD=0.42 -0.03,0.87 0.068 - 
 Quest 
Appliance adaptation: duration longer than 
30 days (3 months) 
1a RR=7.00 0.38,129.93 0.192 - 
 Quest 
Appliance handling: very difficult (3 
months) 
1a RR=1.00 0.36,2.75 1.000 - 
 Quest Appliance noticibility (3 months) 1a RR=0.31 0.18,0.53 <0.001 - 
 Quest Irritation of soft tissues (0 mo) 1b RR=1.84 1.18,2.87 0.007 - 
 Quest Irritation of soft tissues (1 month) 1b RR=1.75 0.63,4.89 0.286 - 
 Quest Irritation of soft tissues (3 months) 1b RR=7.00 0.39,125.99 0.187 - 
 Quest 
General activity problems in Likert scale (1 
day) 
1g MD=0.49 -0.02,1.00 0.058 - 
 Quest 
General activity problems in Likert scale (2 
days) 
1g MD=0.74 0.16,1.32 0.013 - 
 Quest 
General activity problems in Likert scale (3 
days) 
1g MD=0.65 0.13,1.17 0.014 - 
 Quest 
General activity problems in Likert scale (4 
days) 
1g MD=0.70 0.22,1.18 0.004 - 
 Quest 
General activity problems in Likert scale (5 
days) 
1g MD=0.47 0.04,0.90 0.033 - 
 Quest 
General activity problems in Likert scale (6 
days) 
1g MD=0.48 0.15,0.81 0.004 - 
 Quest 
General activity problems in Likert scale (7 
days) 
1g MD=0.47 0.12,0.82 0.009 - 
 Quest 
General activity problems in Likert scale 
(14 days) 
1g MD=0.25 -0.05,0.55 0.097 - 
 Quest Oral symptoms in Likert scale (1 day) 1g MD=-0.04 -0.44,0.36 0.845 - 
 Quest Oral symptoms in Likert scale (2 days) 1g MD=0.22 -0.16,0.60 0.252 - 
 Quest Oral symptoms in Likert scale (3 days) 1g MD=0.17 -0.22,0.56 0.393 - 
 Quest Oral symptoms in Likert scale (4 days) 1g MD=0.15 -0.20,0.50 0.400 - 
 Quest Oral symptoms in Likert scale (5 days) 1g MD=0.13 -0.24,0.50 0.494 - 
 Quest Oral symptoms in Likert scale (6 days) 1g MD=0.15 -0.20,0.50 0.405 - 
 Quest Oral symptoms in Likert scale (7 days) 1g MD=0.25 -0.08,0.58 0.136 - 
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 Quest Oral symptoms in Likert scale (14 days) 1g MD=0.02 -0.31,0.35 0.905 - 
 Quest Sleep disturbance (1 week) 1k RR=1.00 0.15,6.64 1.000 - 
 Quest Sleep disturbance (1 month) 1k RR=1.50 0.27,8.34 0.643 - 
 Quest Sleep disturbance (3 months) 1k RR=0.33 0.01,7.87 0.496 - 
 Quest Analgesic consumption (1 week) 1k RR=4.00 0.47,33.73 0.203 - 
 Quest Analgesic consumption (1 month) 1k RR=5.00 0.25,99.95 0.292 - 
 Quest Analgesic consumption (3 months) 1k RR=NE - - - 
 Quest Pain pattern: mainly during day (1 week) 1k RR=1.00 0.46,2.17 1.000 - 
 Quest Pain pattern: mainly during day (1 month) 1k RR=0.80 0.24,2.69 0.719 - 
 Quest Pain pattern: mainly during day (3 months) 1k RR=1.00 0.22,4.56 1.000 - 
 Quest Pain pattern: same day and night (1 week) 1k RR=1.00 0.60,1.66 1.000 - 
 Quest Pain pattern: same day and night (1 month) 1k RR=1.33 0.95,1.88 0.100 - 
 Quest 
Pain pattern: same day and night (3 
months) 
1k RR=1.00 0.80,1.25 1.000 - 
 Quest Initial pain: after 3 hours (1 week) 1k RR=0.04 0.01,0.25 0.001 - 
 Quest Initial pain: after 3 hours (1 month) 1k RR=0.05 0.01,0.23 <0.001 - 
 Quest Initial pain: after 3 hours (3 months) 1k RR=0.15 0.06,0.35 <0.001 - 
        
Speech Aud. Anal. 
Upper boundary frequency of the /s/ sound 
in the middle of the word (0 mo) 
3bef MD=-722.29 -1500.00,94.26 0.083 97 
 Aud. Anal. 
Upper boundary frequency of the /s/ sound 
in the middle of the word (1 month) 
3bef MD=-441.12 -986.22,103.98 0.113 95 
 Aud. Anal. 
Upper boundary frequency of the /s/ sound 
in the middle of the word (1 week) 
2ef MD=-312.18 -600.98,-23.39 0.034 75 
 Aud. Anal. 
Upper boundary frequency of the /s/ sound 
in the middle of the word (3 months) 
1b MD=-443.00 -647.06,-238.94 <0.001 - 
 Aud. Anal. 
Upper boundary frequency of the /s/ sound 
in the start of the word (1 day) 
2ef MD=-39.87 -195.65,115.91 0.616 0 
 Aud. Anal. 
Upper boundary frequency of the /s/ sound 
in the start of the word (1 week) 
2ef MD=-216.93 -372.62,-61.25 0.006 0 
 Aud. Anal. 
Upper boundary frequency of the /s/ sound 
in the start of the word (1 month) 
2ef MD=-120.22 -282.73,42.29 0.147 0 
 Clin. Speech performance by expert (1 day) 1e MD=0.02 -0.04,0.08 0.497 - 
 Clin. Speech performance by expert (1 week) 1e MD=0.24 0.13,0.35 <0.001 - 
 Clin. Speech performance by expert (1 month) 1e MD=0.07 0.01,0.13 0.019 - 
 Clin. Speech performance by layperson (1 day) 2ef MD=0.00 -0.22,0.21 0.989 - 
 Clin. Speech performance by layperson (1 week) 2ef MD=0.82 0.58,1.05 <0.001 - 
 Clin. 
Speech performance by layperson (1 
month) 
2ef MD=0.60 0.31,0.90 <0.001 - 
 Clin. 
Speech pathologist's assessment of vowels 
(1 day) 
1f MD=-0.25 -1.73,1.23 0.741 - 
 Clin. 
Speech pathologist's assessment of vowels 
(1 week) 
1f MD=2.88 0.58,5.18 0.014 - 
 Clin. 
Speech pathologist's assessment of vowels 
(1 month) 
1f MD=0.12 -0.58,0.82 0.737 - 
 Clin. 
Speech pathologist's assessment of palatal 
consonants (1 day) 
1f MD=1.02 -0.58,2.62 0.210 - 
 Clin. 
Speech pathologist's assessment of palatal 
consonants (1 week) 
1f MD=2.19 0.93,3.45 0.001 - 
 Clin. 
Speech pathologist's assessment of palatal 
consonants (1 month) 
1f MD=0.29 0.13,0.45 <0.001 - 
 Clin. 
Speech pathologist's assessment of alveolar 
consonants (1 day) 
1f MD=1.79 0.55,3.03 0.005 - 
 Clin. 
Speech pathologist's assessment of alveolar 
consonants (1 week) 
1f MD=2.81 1.56,4.06 <0.001 - 
 Clin. 
Speech pathologist's assessment of alveolar 
consonants (1 month) 
1f MD=0.35 -0.05,0.75 0.087 - 
 Clin. 
Speech pathologist's assessment of blends 
(1 day) 
1f MD=0.25 -0.28,0.78 0.351 - 
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 Clin. 
Speech pathologist's assessment of blends 
(1 week) 
1f MD=0.83 0.16,1.50 0.015 - 
 Clin. 
Speech pathologist's assessment of blends 
(1 month) 
1f MD=0.04 -0.02,0.10 0.215 - 
 Quest Speech disturbance (3 months) 2ab RR=8.90 1.15,68.69 0.036 0 
 Quest 
Speech disturbance: high intensity (3 
months) 
1a RR=10.97 0.67,179.68 0.093 - 
 Quest 
Speech disturbance: duration longer than 
30 days (3 months) 
1a RR=9.68 0.58,160.26 0.113 - 
 Quest 
Perception of articulation change (0 
month) 
1b RR=2.33 1.34,4.05 0.003 - 
 Quest 
Perception of articulation change (1 
month) 
1b RR=25.00 1.60,391.13 0.022 - 
 Quest 
Perception of articulation change (3 
months) 
1b RR=11.00 0.66,184.62 0.096 - 
 Quest 
Others’ observation of articulation change 
(0 month) 
1b RR=4.00 1.68,9.50 0.002 - 
 Quest 
Others’ observation of articulation change 
(1 month) 
1b RR=15.00 0.92,243.52 0.057 - 
 Quest 
Others’ observation of articulation change 
(3 months) 
1b RR=5.00 0.26,97.00 0.287 - 
 Quest 
Avoidance of some types of conversations 
(0 month) 
1b RR=4.50 1.14,17.83 0.032 - 
 Quest 
Avoidance of some types of conversations 
(1 month) 
1b RR=7.00 0.39,125.99 0.187 - 
 Quest 
Avoidance of some types of conversations 
(3 months) 
1b RR=NE - - - 
        
Eating Quest Eating problems (3 months) 2ab RR=5.35 0.97,29.50 0.054 0 
 Quest Eating problems: high intensity (3 months) 1a RR=1.35 0.69,2.63 0.385 - 
 Quest 
Eating problems: duration longer than 30 
days (3 months) 
1a RR=3.72 0.44,31.27 0.226 - 
 Quest Eating hard foods problems (3 months) 1a RR=1.17 0.95,1.43 0.136 - 
 Quest 
Eating hard foods problems: high intensity 
(3 months) 
1a RR=1.29 0.63,2.61 0.487 - 
 Quest Eating soft foods problems (3 months) 1a RR=2.00 0.94,4.25 0.071 - 
 Quest 
Eating soft foods problems: high intensity 
(3 months) 
1a RR=NE   - 
 Quest Mastication problems (0 month) 1b RR=1.30 0.98,1.71 0.067 - 
 Quest Mastication problems (1 month) 1b RR=2.25 0.86,5.92 0.100 - 
 Quest Mastication problems (3 months) 1b RR=9.00 0.52,155.24 0.130 - 
 Quest Eating problems in Likert scale (1 day) 1g MD=0.74 0.18,1.30 0.010 - 
 Quest Eating problems in Likert scale (2 days) 1g MD=1.05 0.45,1.65 0.001 - 
 Quest Eating problems in Likert scale (3 days) 1g MD=1.09 0.46,1.72 0.001 - 
 Quest Eating problems in Likert scale (4 days) 1g MD=1.08 0.44,1.72 0.001 - 
 Quest Eating problems in Likert scale (5 days) 1g MD=1.12 0.48,1.76 0.001 - 
 Quest Eating problems in Likert scale (6 days) 1g MD=1.21 0.61,1.82 <0.001 - 
 Quest Eating problems in Likert scale (7 days) 1g MD=1.11 0.50,1.72 <0.001 - 
 Quest Eating problems in Likert scale (14 days) 1g MD=1.11 0.49,1.73 <0.001 - 
        
Dental form Model Intercanine width (after Tx) 2ch MD=0.62 0.08,1.16 0.025 0 
 Model Interpremolar width (after Tx) 2ch MD=-1.47 -3.41,0.48 0.139 87 
 Model Intermolar width (after Tx) 2ch MD=-0.63 -2.45,1.19 0.499 86 
 Model Arch length to molars (after Tx) 2ch MD=-0.48 -1.75,0.79 0.461 70 
 Model Amount of Enamel Reduction (after Tx) 1c MD=-0.67 -0.84,-0.50 <0.001 - 
 Model Arch length to canines (after Tx) 1h MD=-0.26 -0.91,0.39 0.430 - 
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 Model Arch length: lateral segment (after Tx) 1h MD=0.54 -0.61,1.69 0.358 - 
        
Cephalometric Ceph. 
Sagittal position of the lower incisor to the 
A-Pg line (after Tx) 
1h MD=1.04 -0.00,2.08 0.051 - 
 Ceph. 
Sagittal position of the lower incisor apex 
on the mandibular plane (after Tx) 
1h MD=-1.16 -4.41,2.09 0.484 - 
 Ceph. 
Inclination of the lower incisor to the 
mandibular plane (after Tx) 
1h MD=0.08 -1.34,1.50 0.912 - 
 Ceph. Y axix (sella turcica to gnathion) (after Tx) 1h MD=0.68 -0.57,1.93 0.287 - 
 Ceph. Lower anterior face height (after Tx) 1h MD=0.20 -0.94,1.34 0.730 - 
 Ceph. Upper lip to esthetic line (after Tx) 1h MD=0.00 -0.74,0.74 1.000 - 
 Ceph. Lower lip to esthetic line (after Tx) 1h MD=0.60 -0.49,1.69 0.280 - 
 Ceph. 
Sagittal anchorage loss of the upper first 
molar (after Tx) 
1j MD=-0.82 -1.09,-0.56 <0.001 - 
        
Excluded Quest Oral hygiene problems (Likert scale) 0g Missing data - - - 
 Quest Sever oral pain 0g Missing data - - - 
 Quest Recovery time for each problem 0g Missing data - - - 
 Quest Oral pain at tongue (VAS scale) 0k Missing data - - - 
 Quest Oral pain at cheeks (VAS scale) 0k Missing data - - - 
 Quest Oral pain at lips (VAS scale) 0k Missing data - - - 
 Quest Oral pain at gums (VAS scale) 0k Missing data - - - 
 Quest Oral pain at face (VAS scale) 0k Missing data - - - 
 Quest Oral pain at jaw (VAS scale) 0k Missing data - - - 
 Quest 
Total oral pain during the treatment (VAS 
scale) 
0k Missing data - - - 
 Quest Sleep disturbance 0k Missing data - - - 
 Quest Analgesic consumption 0k Missing data - - - 
 Quest Pain pattern: day vs night vs both 0k Missing data - - - 
 Quest Timing of first pain: <3 hours vs > 3hours 0k Missing data - - - 
RR, relative risk; MD, mean difference; IRR, incidence rate ratio; OR, odds ratio; SMD, standardized mean difference; CI, confidence 
interval; NE, not estimable; WSL, white spot lesion; F, average fluorescence loss within a lesion relative to the fluorescence level of 
healthy tissue surrounding the lesion; Q, integrated fluorescence loss over the lesion; VAS, visual analogue scale; Tx, treatment 
†
a, Caniklioglu 2005; b, Khattab 2013; c, Khattab 2014; d, Lombardo 2013; e, Rai 2013; f, Rai 2014; g, Shalish 2012; h, Soldanova 
2011 and 2012; i, van der Veen 2010; j, Venkatesh 2015; k, Wu 2010 and 2011. 
*Generalized estimating equations adopting a negative binomial distribution for continuous outcomes and binomial distribution for 
binary outcomes were used to calculate newly formed white spot lesions on the treated side of each jaw, while accounting for within-
patient clustering. Multivariable estimates correspond to IRRs or ORs adjusted for type of jaw (maxilla or mandible), patient age, 
treatment duration, and number of baseline lesions.  
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Table S6 
Details of the GRADE assessment for the main outcomes of this systematic review (outcome numbering corresponds to the order of Table 3) 
Outcome Risk of Bias Inconsistency Indirect-ness Imprecision 
Publication 
bias 
Large Effect 
Dose 
Response 
Residual 
Confounding 
Outcome 1 
Starts from "low", due to the 
inclusion of non-randomized 
studies. Downgraded further by 
one point due to serious 
limitations (high risk of bias). 
High heterogeneity; confidence 
regarding decision unaffected; 
heterogeneity affects just the 
precision of the estimate. 
Directly 
relevant 
Adequate sample 
No evidence of 
bias 
No reason to rate up 
No dose 
response 
relation 
assessment. 
Cannot be ruled 
out. 
Outcome 2 Same as Outcome 1 
High heterogeneity; confidence 
regarding decision unaffected; 
heterogeneity affects just the 
precision of the estimate. 
Same as 
Outcome 1 
Inadequate sample; the 
95% CI includes both the 
null effect and large effect 
values, which indicates 
imprecision. 
Same as 
Outcome 1 
Large effect 
magnitude; however 
no rating up due 
existing concerns 
regarding risk of bias 
and imprecision 
Same as 
Outcome 1 
Same as Outcome 
1 
Outcome 3 Same as Outcome 1 
Low heterogeneity; no reason to 
downgrade 
Same as 
Outcome 1 
Adequate sample 
Same as 
Outcome 1 
No reason to rate up 
Same as 
Outcome 1 
Same as Outcome 
1 
Outcome 4 Same as Outcome 1 
Low heterogeneity; no reason to 
downgrade 
Same as 
Outcome 1 
Same as Outcome 1 
Same as 
Outcome 1 
Same as Outcome 2 
Same as 
Outcome 1 
Same as Outcome 
1 
Outcome 5 Same as Outcome 1 
Low heterogeneity; no reason to 
downgrade 
Outcome not 
necessarily 
directly 
relevant. 
Treatment 
mechanics 
and wire 
might have 
confounded 
the results. 
Adequate sample 
Same as 
Outcome 1 
No reason to rate up 
Same as 
Outcome 1 
Same as Outcome 
1 
Outcome 6 Same as Outcome 1 
High heterogeneity, which could not 
be explained by subgroup analysis, 
while our confidence regarding 
decision is affected by it (trials on 
both sides of the forest plot) 
Same as 
Outcome 5 
Adequate sample 
Same as 
Outcome 1 
No reason to rate up 
Same as 
Outcome 1 
Same as Outcome 
1 
Outcome 7 Same as Outcome 1 No heterogeneity assessment 
Same as 
Outcome 1 
Adequate sample 
Same as 
Outcome 1 
No reason to rate up 
Same as 
Outcome 1 
Same as Outcome 
1 
. 
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 Table S7 
GRADE summary of findings table for the main outcomes of the systematic review according to the sensitivity analysis 
 Sensitivity analysis Original analysis 
 Illustrative comparative effects (95% CI)       
Outcomes Labial appliances Lingual appliances Change 
Patients 
(trials) 
GRADE Effects GRADE Effects 
  Assumed risk Corresponding risk         
Oral discomfort; patient-reported (0.5-
3 months) 
529 patient per 1000 
1648 more patients per 1000 
(204 to 5937 more) 
2 pCCT 
omitted 
34 (1) 
Moderate 
⊕⊕⊕⊝1 
SMD=1.90 (0.27,3.53); 
P<0.05 
Very low 
⊝⊝⊝⊝ 
SMD=0.78 (0.18,1.38); 
P<0.05 
   Assumed change Corresponding change          
Upper boundary frequency of the /s/ 
sound in the middle of the word; 
auditory analysis (1 month) 
The upper boundary frequency 
decreased on average by 114.80 Hz 
in the labial groups 
Decrease by 1096.20 Hz (95% CI: 
830.45 Hz to 1361.95 Hz decrease) 
compared to the labial group. 
2 pCCTs 
omitted 
34 (1) 
Moderate 
⊕⊕⊕⊝2 
MD=-1096.20 (-1361.95,-
830.45); P<0.05 
Very low 
⊝⊝⊝⊝ 
MD=-441.12 (-
986.22,203.98) ; P>0.05 
   Assumed change Corresponding change          
Speech performance; assessed by 
layperson (1 month) 
 -  - 
2 pCCTs 
omitted 
0 (0) - - 
Very low 
⊝⊝⊝⊝ 
MD=0.60 (0.31,0.90); 
P<0.05 
  Assumed risk Corresponding risk         
Eating difficulty; patient-reported (3 
months) 
 31 patients per 1000* 
 264 more patients per 1000 (16 less to 
5090 more) 
1 pCCT 
omitted 
34 (1) 
Moderate 
⊕⊕⊕⊝2 
RR=9.00 (0.52,155.24); 
P>0.05 
Very low 
⊝⊝⊝⊝ 
RR=5.35 (0.97,29.50); 
P>0.05 
   Assumed change Corresponding change          
Intercanine width; from dental cast 
analysis (after treatment) 
Increase on average by 1.30 mm in 
the labial group 
Increase by 0.69 mm (95% CI: 0.03 
mm to 1.35 mm increase) compared to 
the labial group. 
1 pCCT 
omitted 
52 (1) 
Moderate 
⊕⊕⊕⊝3 
MD=0.69 (0.03,1.35); P<0.05 
Very low 
⊝⊝⊝⊝ 
MD=0.62 (0.08,1.16); 
P<0.05 
   Assumed change Corresponding change          
Intermolar width; from dental cast 
analysis (after treatment) 
Increase on average by 0.80 mm in 
the labial group 
Decrease by 1.59 mm (95% CI: 0.52 
mm to 2.66 mm decrease) compared to 
the labial group. 
1 pCCT 
omitted 
52 (1) 
Moderate 
⊕⊕⊕⊝2 
MD=-1.59 (-2.66,-0.52); 
P<0.05 
Very low 
⊝⊝⊝⊝ 
MD=-0.63 (-2.45,1.19); 
P>0.05 
   Assumed change Corresponding change          
Sagittal anchorage loss of the upper 
first molar during space closure (after 
treatment) 
 -  - 
1 pCCT 
omitted 
0 (0) - - 
Very low 
⊝⊝⊝⊝ 
MD=-0.82 (-1.09,-0.56); 
P<0.05 
CI, confidence interval; MD, mean differences; SMD, standardized mean differences; pCCT, prospective non-randomized clinical trial; RR, relative risk; Tx, treatment. 
*assumed risk extracted from the omitted trial, as the included trial had no events in the control group 
1GRADE starts from high as only randomized trials are included; downgraded by one due to absence of blinding. 
2GRADE starts from high as only randomized trials are included; downgraded by one due to absence of blinding; very large effect magnitude, but no upgrade, due to existing limitations. 
3GRADE starts from high as only randomized trials are included; downgraded by one due to the possibility of residual confounding (archwire differences between the lingual and the 
labial groups might have influenced the dental arch form and width). 
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Table S8 
Supplementary Information 
 
Communications with trialists 
 Dr. Shalish (trial Shalish 2011) was contacted for clarifications, any extra trial data, and 
missed trials: responded that trial was expanded for publication of additional papers and no 
data could be provided. 
 Dr. Rai (trials Rai 2013; Rai 2014) contacted for clarifications, any extra trial data, and 
missed trials: responded that he would be willing to help and received modified extraction 
form with questions; waiting for response. 
 Dr. Khattab (trials Khattab 2013; Khattab 2014) contacted for clarifications, any extra trial 
data, and missed trials: responded that he would be willing to help and received modified 
extraction form with questions; provided clarifications about wire/bracket information and 
confirmed that the two trials are unique. 
 Dr. Soldanova (trial Soldanova 2011; 2012) contacted for clarifications, any extra trial data, 
and missed trials: responded that she would be willing to help and received modified 
extraction form with questions; waiting for response. 
 Dr. Caniklioglu (trial Caniklioglu 2013) contacted for clarifications, any extra trial data, and 
missed trials: did not respond to e-mail. Contacted the second author, Dr. Oztürk with the 
same query: responded that trial is of prospective nature and can be included. 
 Dr. van der Veen (trial van der Veen 2010) contacted for raw trial data: responded by sending 
all raw data in SPSS file format. 
 Dr. Rabie (trials Wu 2010, 2011) contacted for raw trial data, clarifications, any extra trial 
data, and missed trials: Dr. Rabie responded that he has retired. Prompted me to contact Dr. 
McGrath. Dr. McGrath contacted, but did not respond. 
 
Author contributions 
19 
 
SNP conceived the idea and wrote the first draft of the protocol. SNP, LG, AJ, TE, and CB revised the 
protocol. SNP performed the literature searches, extracted search hits, and did screening by title. SNP 
and LG did study selection by abstract and full-text, did data extraction, and assessed the risk of bias 
in duplicate, while AJ, TE, and CB resolved any conflicts that arose. SNP handled communications 
with trialists, performed the statistical analysis, and wrote the first draft of the manuscript. SNP, LG, 
AJ, TE, and CB assisted in the interpretation of the results and revised the manuscript draft. SNP 
submitted the manuscript, is the guarantor and responsible for the accuracy of the data and for future 
updates of the review. 
 
 
Post hoc changes to the protocol 
 The outcomes chosen for the GRADE analyses were modified, according to the trials that 
were identified. 
 Contrary to the original analysis plan, we used odds ratios and incidence rate ratios for one 
identified trial for the analysis, as the raw data from this split-mouth trial were re-analyzed 
through multivariable regression modeling adopting a binomial or negative binomial 
distribution, as appropriately. 
 We used the standardized mean difference as effect measure in one instance, as binary and 
continuous measurements of oral discomfort were combined into the same meta-analysis. 
 Subgroup analyses and assessments of reporting biases were planned, but could not be 
performed due to the limited number of trials included in the meta-analyses. We could not 
perform any subgroup analyses, as less than 5 trials were included in every meta-analysis, and 
trial characteristics overlapped with study design characteristics. 
 The number needed to treat was planned to be used to clinically translate the results of 
statistically significant meta-analyses of binary outcomes, but no significant binary outcomes 
existed. 
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 We added an extra exploratory analysis based on meta-epidemiological methods to further the 
planned sensitivity analysis of including only RCT. This is clearly denoted as an exploratory 
analysis in the sensitivity analysis. 
